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Abstract
Hybrid PET/MRI can non-invasively improve epileptic focus (EF) localization prior to
surgical resection in drug-resistant epilepsy (DRE), especially when MRI is negative. In this
thesis, we developed an
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F-fluorodeoxyglucose (FDG) PET-guided diffusion tractography

(PET/DTI) approach to assess white matter (WM) integrity in MRI-negative DRE and
evaluated its potential impact on epilepsy surgical planning. To validate the potential of
PET/MRI, we first evaluated the diagnostic competence of PET/MRI in DRE and found that
PET/MRI provides similar diagnostic information as PET/CT (current clinical standard). For
the PET/DTI approach, we used asymmetry index (AI) mapping of FDG-PET to guide WM
fiber tractography around glucose hypometabolic brain regions (potential EF). Fiber
tractography was repeated in the contralateral brain region (opposite to EF), which served as
a control for this study. WM fibers were quantified by calculating the fiber count, mean
fractional anisotropy (FA), mean fiber length, and mean cross-section of each fiber bundle.
WM integrity was assessed through fiber visualization and by normalizing ipsilateral fiber
measurements to contralateral fiber measurements. The added value of PET/DTI in clinical
decision-making was assessed by an experienced epileptologist. In over 60% of the patient
cohort (n = 14), AI mapping findings were concordant with clinical reports on seizure-onset
zone. Mean FA, fiber count, and mean fiber length were decreased in 14/14 (100%), 13/14
(93%), and 12/14 (86%) patients, respectively. PET/DTI improved diagnostic confidence in
10/14 (71%) patients and indicated surgical candidacy be reassessed in 3/6 (50%) patients
who had not undergone surgery. FDG-PET coupled with diffusion tractography can be a
powerful tool for detecting EF and assessing WM integrity around EF in MRI-negative
epilepsy. PET/DTI could further enhance clinical decision-making in epilepsy surgery.

Keywords
PET/MRI, PET/CT, drug-resistant epilepsy, fluorodeoxyglucose, MRI-based attenuation
correction, standardized uptake value, asymmetry index, diffusion tractography
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Summary for Lay Audience
Drug-resistant epilepsy (DRE) is a serious neurological condition affecting approximately
one in three epilepsy patients. Surgical resection of the seizure-onset zone in the brain can
alleviate seizure occurrence and improve quality of life. However, about 50% of DRE
patients continue to have seizures after surgery. Poor surgical outcomes can occur when the
seizure-onset zone and its relationships with surrounding brain regions are not properly
characterized. Furthermore, absence of a clear structural lesion in the brain can further
decrease a patient’s chances of achieving long-term seizure freedom after surgery. Recent
advances in medical imaging have seen the increased use of MRI and PET to non-invasively
map out brain structure and function in epilepsy. Specifically, multimodal brain imaging
combining PET and MRI (hybrid PET/MRI) can improve detection of the seizure-onset zone
prior to surgical resection and could potentially improve surgical outcomes, especially in
MRI-negative epilepsy. In this thesis, we developed a hybrid PET/MRI approach combining
PET and diffusion tractography to non-invasively assess structural integrity around seizureonset zones in MRI-negative DRE and then evaluated the potential clinical impact of this
PET/MRI approach on epilepsy surgical planning. To validate the potential of PET/MRI, we
first assessed the diagnostic competence of PET/MRI in DRE and found that PET/MRI
provides similar diagnostic information as PET/CT (current clinical standard). For the
PET/MRI approach, we used PET to detect seizure foci as brain regions showing decreased
PET activity and then used diffusion tractography to assess structural integrity around seizure
foci. The added value of the PET/MRI approach in guiding clinical decision-making was
evaluated by a senior neurologist. Our PET/MRI approach revealed structural alterations
around seizure foci and improved diagnostic confidence in the majority of our DRE patient
cohort. Furthermore, the PET/MRI approach indicated surgical candidacy be reassessed in
some patients who had not undergone surgery. PET/MRI can be a powerful tool for detecting
seizure foci and assessing structural integrity around seizure foci in DRE. Our hybrid
PET/MRI approach could be used to further enhance clinical decision-making in epilepsy
surgery.
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Chapter 1!!

1!

Introduction to Epilepsy Imaging

1.1! Background and Motivation
Epilepsy affects approximately 50 million people worldwide and is a chronic
neurological disorder characterized by seizures – spontaneous, synchronized neuronal
activity – arising from pathological changes to brain networks.1,2 Seizures typically
originate in a brain region called the epileptic focus (EF) and then propagate throughout
surrounding neural networks.3,4 While the exact underlying physiological mechanisms
responsible for seizure activity remain unknown5, one potential mechanism for seizure
propagation may be due to removal of interneuronal inhibition by abnormally arranged
neural networks around the EF.6 Failure to control seizures in epilepsy has been
associated with increased societal burden and in some patients, may lead to anxiety,
depression, and chronic migraines.5
Epilepsy is usually treated in the clinical setting using either medication, dietary
restrictions, surgery, or neurostimulation.5 When a patient is first diagnosed with
epilepsy, anti-epileptic drugs (AEDs) are often administered in an attempt to control
seizures. Most epilepsy patients achieve full seizure control after being administered
AEDs, however, approximately 30% of epilepsy patients have drug-resistant epilepsy
(DRE).3,4,7 DRE is a serious neurological condition that is clinically diagnosed when
seizures persist after administering at least two adequate trials of AEDs.8 If left untreated,
DRE can lead to progressive memory decline, psychological impairment, social
stigmatization, decreased quality of life, and increased risk of sudden death in epilepsy
(SUDEP).2,5,8
DRE can be treated by surgically removing the EF which is a viable option for alleviating
seizure occurrence and improving overall quality of life.9,10 However, only about 50% of
DRE patients achieve long-term seizure freedom after surgery.11,12 Poor surgical
outcomes can occur when the EF and its relationships with surrounding neural networks
are poorly characterized prior to surgical resection.13 Past studies have shown that
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patients with multifocal epilepsy or epilepsy involving the eloquent cortex are at
increased risk of post-surgical complications such as visual, speech, motor, or cognitive
impairments.3,4,8,14 Accurate localization of the EF and proper characterization of
surrounding neural networks are therefore crucial to improving surgical outcomes and
ensuring long-term seizure freedom in DRE.
Before surgery, DRE patients undergo presurgical evaluation to detect the EF and assess
potential surgical candidacy. Presurgical evaluation protocols typically consist of patient
history,

neuropsychological

assessment,

and

prolonged

scalp

video-

electroencephalography (VEEG) to record seizure events in the brain.7 The current gold
standard for localizing the EF is intracranial EEG (IC-EEG), where surgeons place
electrodes in or around the patient’s scalp to record seizure events15,16 (see Figure 1.1).

Figure 1.1: IC-EEG brain monitoring. Electrodes are placed on the surface of the
patient’s brain to record seizure events. Image courtesy of Dr. David Steven (Chief/Chair,
Neurosurgery, Western University).

However, IC-EEG is an invasive procedure that is expensive, time-consuming and carries
risk of side effects such as hemorrhage, edema, or infection.7,16 Structural brain imaging

3

using magnetic resonance imaging (MRI) has been effective in reducing costs and
improving patient quality of care by aiding or minimizing IC-EEG use. MRI can identify
structural lesions (EF) that may be removed by surgical resection if MRI findings are
concordant with VEEG and IC-EEG.7,9 However, approximately one in four DRE
patients have an EF that is not visible (non-lesional) and cannot be detected by MRI.17
Consequently, past studies have shown that patients with no clear lesion on anatomical
MRI (MRI-negative epilepsy) are likely to have recurrent seizures after surgery.11,12
Thus, MRI-negative epilepsy has brought on an increasing demand for improved noninvasive methods for localizing the EF prior to surgical resection.
Recent advances in neuroimaging have provided alternative, non-invasive ways to
visualize brain structures in vivo and may have promising applications in epilepsy
surgical evaluation. In MRI-negative epilepsy, functional brain imaging using
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F-

fluorodeoxyglucose positron emission tomography (FDG-PET) can identify the EF as
brain

areas

showing

decreased

FDG

uptake,

also

known

as

glucose

hypometabolism.7,10,13,18 While FDG-PET is now well established in most epilepsy
surgical centers, utility of PET in epilepsy surgery continues to evolve.7 Recent studies
have also shown that advanced MRI techniques such as diffusion tensor imaging (DTI)
can map out white matter fiber pathways in the brain to investigate structural connections
between the EF and surrounding neural networks.5,13
Although separate FDG-PET and MRI brain scanning remains the current clinical
standard-of-care for epilepsy imaging, some DRE patients continue to have seizures after
surgical treatment especially when MRI is negative or equivocal.10 Separate acquisition
of PET and MRI, which can be several months apart, can introduce registration bias and
may lead to inaccurate EF localization responsible for surgical failure.19,20 There is
emerging evidence that multimodal brain imaging combining PET and MRI may further
improve sensitivity of EF detection over standalone PET, MRI, or IC-EEG.7 Indeed,
simultaneous acquisition of PET and MRI using hybrid PET/MRI may shed new insight
into DRE pathophysiology and could potentially improve surgical outcomes especially in
MRI-negative epilepsy.20–24 Furthermore, while clinical adoption of hybrid PET/MRI is
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beginning to take place in some epilepsy surgical centers, the potential utility of
combined PET and DTI in epilepsy surgical evaluation is still yet to be fully assessed.

1.2! Positron Emission Tomography
1.2.1!

Glucose Hypometabolism in Epilepsy

Positron emission tomography (PET) is a functional imaging modality that is now widely
accepted as clinical standard-of-care in most epilepsy surgical centers. Absence of a clear
lesion on anatomical MRI is a common indication for PET in DRE.7 While other PET
tracers have been proposed for epilepsy brain imaging,
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F-fluorodeoxyglucose PET

(FDG-PET) has become well established as the most sensitive functional imaging
approach for detecting the EF especially when MRI is negative or equivocal.7,18 In MRInegative DRE, interictal FDG-PET can detect the EF as brain regions showing decreased
FDG uptake (glucose hypometabolism).7,10,13,18 Glucose hypometabolism, which can be
observed both within the EF and in surrounding neural networks13,18, has been associated
with spread of epileptic activity25 as well as cognitive impairment.26 Furthermore,
severity and location of FDG-PET hypometabolism in epilepsy may predict surgical
outcome.18,27 In temporal lobe epilepsy, extent of FDG-PET hypometabolism within the
EF has been correlated with long-term seizure freedom after surgery.28,29 Conversely,
FDG-PET hypometabolism that extends beyond the EF, which can occur in bitemporal
and extratemporal epilepsies, may lead to poor surgical outcome.27,30,31 While the exact
mechanisms underlying glucose hypometabolism in epilepsy remain unclear, some
studies have suggested that decreased synaptic activity due to neuron loss from recurrent
epileptic insults may be responsible for the metabolic alterations observed in DRE.25,32
Neuronal damage has been previously observed using histopathological staining33 and
may be responsible for metabolic abnormalities in and around the EF.25 Interestingly,
suppression of glucose activity in DRE may also be due to inhibition of afferent signals
between the EF and surrounding healthy brain tissue as a potential protective mechanism
against further seizure-associated insult.25,34 Nevertheless, utility of FDG-PET in epilepsy
is evident and further investigation of metabolic dysfunction, as well as its association
with neuronal damage, may shed new insight into DRE pathophysiology and could
potentially improve surgical outcomes, especially in MRI-negative epilepsy.
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1.2.2!

Visual PET Assessment

Glucose hypometabolic regions of interest (ROIs) are typically identified by visual
inspection of FDG-PET images. An example of visual PET assessment revealing a
hypometabolic ROI (potential EF) in the right temporal lobe of an MRI-negative DRE
patient is provided in Figure 1.2. During epilepsy surgical evaluation, visual FDG-PET
assessment can guide electrode placement in the brain during IC-EEG as well as alter the
decision

to

perform

surgery

if

FDG-PET

findings

agree

with

EEG

and

electrophysiological reports.7,28,35

Figure 1.2: Visual FDG-PET assessment shows a clear hypometabolic PET ROI (yellow
circle), indicative of a potential EF, in the right temporal lobe of an MRI-negative
epilepsy patient. Image is displayed using the radiological convention. This patient was
confirmed to have right temporal lobe focal epilepsy, determined based on all available
diagnostic information.
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1.2.3!

Quantitative PET Analysis

Although visual FDG-PET assessment is well established as routine clinical practice in
diagnosis of functional pathologies in epilepsy, visual reads are subject to inter-reader
variability and some hypometabolic brain regions, especially when subtle, can be missed
altogether.20,36,37 As such, efforts have been made to develop more objective, quantitative
approaches to aid visual detection of hypometabolic PET ROIs (potential EF). Early
attempts to quantify FDG-PET in epilepsy measured metabolic asymmetries using
manually defined a priori brain regions commonly interrogated in visual reads38,39,
however, this approach was problematic as it still required manual implementation and
results varied between studies due to different ROI-defining criteria.37 Fortunately, this
approach has been abandoned and FDG-PET quantification has migrated towards more
advanced neuroimaging techniques that use semi-quantitative PET analyses, such as
statistical parametric mapping (SPM) (Wellcome Department of Cognitive Neurology,
Institute of Neurology, London) and asymmetry index (AI) mapping40, to automate
detection of metabolic abnormalities on PET. Several studies have shown that semiquantitative PET analysis can produce metabolic findings consistent with visual FDGPET assessment and may be a reliable tool for aiding EF localization in DRE.20,36,37,40–43
Consequently, visual FDG-PET readings are now typically augmented using statistical
comparison of metabolic values between patients and a healthy control database for
further improving detection of regional FDG-PET abnormalities in epilepsy.

1.2.3.1!

Statistical Parametric Mapping Analysis

Statistical parametric mapping (SPM) is a voxel-based analysis approach that statistically
assesses differences in voxel intensities between two groups of interest (typically a
patient group and a healthy control group).36,37,41 In epilepsy patients, SPM analysis of
FDG-PET can be used to detect metabolic brain abnormalities through statistical
comparison of standardized uptake value (SUV) – activity concentration over time
normalized by net injected dose of FDG and the patient’s body weight – between
epilepsy patients and healthy controls, as is illustrated in Figure 1.3.20 This group-wise
SUV analysis is typically conducted using a user-defined statistical threshold after
spatially normalizing the patient and control PET data to a standard space and correcting
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for global metabolism effects in the brain using an appropriate proportional scaling
technique.37 However, a limitation is that SPM analysis of FDG-PET assesses grouplevel differences in SUV and thus can sometimes fail to detect metabolic abnormalities,
especially interhemispheric asymmetries, in individual patients.37,43

Figure 1.3: SPM analysis can reveal metabolic abnormalities in the brains of epilepsy
patients through statistical comparison of FDG-PET images between patients and healthy
controls. In this MRI-negative temporal lobe epilepsy cohort, FDG-PET hypometabolism
(bright regions using patients < controls) is seen in the middle temporal gyrus. Colorbar
represents t-values (p < 0.001 was considered statistically significant). Adapted from
Shang et al., Am J Neuroradiol (2018).20 Image used with permission from the American
Society of Neuroradiology.
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1.2.3.2!

Asymmetry Index Mapping

To overcome the group-wise limitation of SPM analysis, other semi-quantitative
approaches such as asymmetry index (AI) mapping have been proposed to further
improve specificity of FDG-PET in DRE localization. AI mapping of FDG-PET is an
automated data-driven approach that calculates the voxel-wise difference in glucose
metabolism between hemispheres and can be used to assess metabolic asymmetries in
individual epilepsy patients by considering the contralateral hemisphere (with respect to
EF) as an inherent control.20,40,43 An example of the typical AI mapping analysis
workflow is shown in Figure 1.4.40 After spatially normalizing the patient’s FDG-PET
data to a standard space, the FDG-PET image is flipped about the sagittal plane and a
voxel-wise AI map is calculated as the difference between the unflipped and flipped
images. The AI map is then converted to a z-score AI (ZAI) map, where voxels with
negative ZAI represent FDG-PET hypometabolism (relative to the contralateral
homologous brain region).43 Lastly, the ZAI map is thresholded by a user-defined negative
ZAI value to isolate significant metabolic asymmetries on FDG-PET (potential EF) as
brain regions showing the largest decrease in ZAI.40,43 Past studies have demonstrated that
AI mapping can successfully detect seizure-onset zones showing FDG-PET
hypometabolism (sensitivity: 65-70%) in concordance with clinical reports and
electrophysiological findings37,42,43, suggesting that AI mapping of FDG-PET could be a
very sensitive biomarker for epileptogenicity and may be a promising tool for improving
EF localization in DRE.
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Figure 1.4: Flowchart of a typical AI mapping analysis pipeline. The PET image
(BPND) is spatially normalized, smoothed, and then thresholded to account for intersubject variability in patient anatomy. The thresholded PET image (VBP) is flipped about
the sagittal plane to generate an AI map (VAI). Adapted from Didelot et al., J Nucl Med
(2010).40
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1.3! Diffusion Tensor Imaging
1.3.1!

Water Diffusion

In the human body, water diffuses in tissue at the microscopic level. This diffusion is
commonly referred to as Brownian motion, which is defined as random molecular
movement due to thermal motion.44 Diffusion tensor imaging (DTI) is an advanced MRI
method that models diffusion of water molecules in the brain and can be used to
effectively characterize tissue microstructure in vivo.13,45,46 By non-invasively probing
tissue microstructure, DTI can infer information about tissue integrity and structural
organization in the brain.44,47,48
Water diffusion is not the same in all tissue types. In gray matter (GM) and cerebral
spinal fluid (CSF), water diffuses approximately the same in all directions (isotropic
diffusion) at the spatial resolution of our DTI measurements (~2 mm), while in white
matter (WM), water preferentially diffuses along the fiber bundle pathway (anisotropic
diffusion).47,49 The anisotropic water diffusion in WM is believed to be due to the
physical arrangement of axons that permit water movement parallel to the fiber bundle,
but hinder water movement in the perpendicular direction.49 Loss of anisotropic water
diffusion in WM can be associated with microstructural tissue breakdown and is
implicated in many neurological and neurodegenerative disorders, such as epilepsy,
stroke, multiple sclerosis, and Alzheimer’s Disease.49

1.3.2!

The Diffusion Tensor Model

DTI can non-invasively assess tissue microstructure in the brain using a diffusion tensor
– a mathematical construct used to model water diffusion – which can be visualized as a
3D object and describes the movement of water diffusion at a particular voxel in the brain
(see Figure 1.5).50 Specifically, the shape of the diffusion tensor is characterized by three
eigenvalues (#1, #2, #3) and three eigenvectors (v1, v2, v3) representing the magnitude and
direction of water diffusion along the major axes of the tensor, respectively.44,50 Thus, the
diffusion tensor can describe physical properties of biological tissue, especially in WM
pathways in the brain where water diffusion is inherently anisotropic, by providing
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information about the degree of diffusion anisotropy as well as structural orientation of
neuronal fibers.49
Diffusion tensors have important applications in the assessment of WM pathways known
to be implicated in a variety of neurological disorders, including epilepsy. WM pathways
in the brain can be characterized using DTI-derived scalar values, which are generated by
fitting diffusion tensors to the diffusion-weighted imaging (DWI) data.47,51,52 A common
tensor-derived parameter used to assess WM fiber pathways is fractional anisotropy (FA),
which measures the degree to which water preferentially diffuses along the length of the
fiber bundle.44,46,51 Mathematically, FA is defined as:
2
2
2
1 #(λ1 !-!λ2 ) !+!(λ1 !-!λ3 ) + (λ2 !-!λ3 )
FA!=!"
,
2
2
2
2
#λ1 !+ λ2 !+ λ3

(1.1)

where #1, #2, and #3 are the three eigenvalues in the diffusion tensor.50 The three
eigenvalues are calculated by measuring the apparent diffusion coefficient from the DWI
signal along at least six non-collinear directions and then using these diffusion
measurements to estimate the diffusion tensor ellipsoid.44,47 Because #1 represents
maximal diffusion in anisotropic tissue, FA measures #1 relative to #2 and #3. Thus, FA is
a measure of diffusion anisotropy and is the most common DTI measurement used to
infer information about WM integrity in the brain.44,46,47,49,51,52 Of note, the shape of the
diffusion tensor indicates how anisotropic the tissue is and what FA value is assigned to
that voxel. For example, a completely isotropic tensor will be a perfect spheroid with
equal diffusion vectors pointing in all directions in 3D space (#1 = #2 = #3) and has an FA
value of 0 (no anisotropy). Conversely, in more anisotropic tissue such as WM, the
tensor’s shape will elongate in the direction of maximal diffusion and FA will approach 1
(complete anisotropy).44,50 In epilepsy, FA reduction in WM can reveal widespread
microstructural alterations associated with epileptic activity and may be an important
biomarker in DRE.5,53,54
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Figure 1.5: Isotropic and anisotropic diffusion tensor ellipsoids with the three
eigenvalues labelled. Adapted from Tromp, The Winnower (2016).50

1.3.3!

Diffusion Tractography

WM fiber pathways in the brain can be reconstructed and visualized using advanced
diffusion MRI techniques such as diffusion tractography. Diffusion tractography can noninvasively probe tissue microstructure in vivo and may have promising applications in
neurosurgical planning of epilepsy.49,55 Previous epilepsy studies have shown that
diffusion tractography can effectively reconstruct WM fiber pathways around seizureonset zones as well as assess structural connectivity between EF and surrounding neural
networks.56,57 While diffusion tractography has not yet been adopted as a widespread
clinical tool in epilepsy surgical evaluation, the potential clinical utility of diffusion
tractography is evident and continues to be explored.
Diffusion tractography algorithms use information about diffusion orientation from each
voxel in the DWI data to reconstruct WM fiber pathways in the brain. In general, WM
fiber tracking typically involves three main steps: seeding, propagation, and
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termination.49,58–60 Seeding involves placement of seed points along voxels of interest
with similar diffusion orientation (likely to be connected by a WM fiber pathway) and
these seed points are then used to initiate neural fiber bundle tracking.49,58 While
tractography algorithms use different seeding point criteria and can generate varying
results, some tractography methods have been shown to be superior than others. For
example, streamlines tractography is a multi-directional 3D tractography approach that
can reconstruct WM tracts by assigning each fiber orientation as a 3D vector, rather than
a single seed point used in basic voxel-linking single-directional tractography methods,
and uses that 3D vector to provide more accurate estimations of WM fiber trajectory.59,60
An example of the streamlines tractography seeding approach is provided in Figure 1.6.59
After seeding, the streamlines are then propagated by taking small steps along the fiber
orientation path using a user-defined stepping distance known as the step size.55,61 As
demonstrated in Figure 1.6, choice of step size is critical to ensuring accurate
tractography results.59 Too large of a step size can cause streamlines to deviate and go
into an adjacent WM region, leading to erroneous reconstruction. Conversely, too small
of a step size can be computationally inefficient.58–60 Previous diffusion tractography
studies comparing different fiber tracking parameters in WM fiber pathway
reconstruction have shown that a step size of 0.5–2 mm is a reasonable choice for
ensuring accurate streamline propagation.55,62
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Figure 1.6: Schematic representation of streamlines tractography. Left: Fiber
tractography is initiated using a user-defined seed point (red arrow) and this seed point is
used to link voxels with similar diffusion orientation (likely to be connected by a WM
fiber pathway). Right: Streamlines are propagated along the fiber orientation path at an
incremental distance called the step size (mm). Too large of a step size (white dots) can
cause the streamline to deviate off-course, leading to inaccurate fiber reconstruction.
Adapted from Mori & Tournier (2013).59 Image used with permission from Elsevier.

The last step in WM fiber reconstruction is to terminate the streamlines. Most
tractography algorithms use a termination criterion to stop streamline propagation such as
a whole brain WM mask from a co-registered anatomical T1-weighted image, an FA
threshold (usually FA = 0.1–0.2), or a curvature threshold.55,58 Of note, errors in WM
tractography can still occur due to a variety of other factors such as noise, partial volume
effects, and crossing fibers.49,59,60 To mitigate these errors, accuracy of WM fiber
reconstruction can be further improved by supplying the tractography algorithm with a
priori brain tissue masks – whole-brain WM, GM, and CSF masks – to minimize false
positive and false negative tracts.59
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1.3.4!

Diffusion MRI Image Analysis Pipeline

After DWI are acquired, the data must be preprocessed to correct for noise, motion, and
other image artifacts that can cause biases in DTI scalar maps and WM fiber
tractography.48,52,58,63 However, multiple approaches exist for preprocessing DWI data
and performing diffusion tractography. Indeed, there are numerous DWI preprocessing
pipelines available that offer different methods of data correction and can lead to varying
FA and tractography results.64–66 It is therefore crucial to select appropriate preprocessing
steps to ensure accurate and reliable results. We have put together a robust diffusion MRI
image analysis pipeline, illustrated in Figure 1.7, that can handle clinical data that are
susceptible to noise, subject motion, as well as GM and WM pathologies. Our pipeline
uses a variety of different diffusion MRI software packages64–70 to preprocess the DWI
data and output an FA map as well as images that can be used to perform WM fiber
tractography (see section 3.2.3 for further details).

Figure 1.7: Diffusion MRI image analysis pipeline. DWI data were preprocessed using
a variety of different image processing software packages to generate an FA map and
images that can be used to visualize WM fiber pathways in the brain using diffusion
tractography.

To validate the accuracy of this pipeline in reconstructing WM fiber pathways in the
brain, we empirically evaluated the pipeline using a ground-truth WM phantom from the
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ISMRM 2015 Tractography Challenge71,72 (see Appendix A). Using the raw DWI as
input, our pipeline can generate a whole-brain tractogram showing all the WM fiber
pathways in the brain, as illustrated in a representative epilepsy patient in Figure 1.8.

Figure 1.8: Raw DWI data from an epilepsy patient preprocessed using our in-house
diffusion MRI image analysis pipeline to generate WM fiber pathways in the brain via
diffusion tractography.

1.4! Hybrid PET/MRI in Epilepsy Imaging
The current clinical standard-of-care epilepsy imaging protocol for assessing structural
and functional abnormalities in the brain, indicative of potential EF, is 1.5T/3T MRI
followed by PET and computed tomography (PET/CT).22 Separate acquisition of PET
and MRI, which in some cases may be several months apart, can be problematic and may
result in misalignment and motion biases, making it difficult to accurately detect the
seizure-onset zone in the brain.19 These co-registration errors can be obviated using
hybrid PET/MRI scanners, which allow simultaneous acquisition of PET and MRI, and
may have promising applications in the clinical management of epilepsy. Furthermore,
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hybrid PET/MRI may be especially useful in improving EF detection through further
advancements in PET quantification.73–76 However, concerns over PET bias from MRIbased attenuation correction approaches have limited clinical adoption of hybrid
PET/MRI.77,78 A few epilepsy studies have attempted to investigate whether these PET
biases impact clinical diagnosis20–22,43,79, however, these studies did not compare FDGPET/MRI findings against the current clinical standard FDG-PET/CT, IC-EEG, surgical
outcome and gold-standard histopathology. Thus, the diagnostic equivalency of
PET/MRI against PET/CT in DRE needs to be further assessed, especially when
improved

brain

MRI-based

attenuation

correction

approaches

(for

example

RESOLUTE)80 are used for PET reconstruction.
Another promise PET/MRI holds in clinical management of epilepsy is the colocalization of PET with advanced functional and structural MRI for brain connectivity
mapping.56 Specifically, the potential clinical utility of combining PET and DTI for
epilepsy surgical evaluation is yet to be fully investigated. The integration of FDG-PET
and diffusion tractography may shed new insight into seizure-related structural
abnormalities in and around the EF, which could minimize potential risks associated with
surgical resection and improve patient outcomes, especially in MRI-negative epilepsy or
non-localizing epilepsy where IC-EEG and MRI findings lack concordance.15,56

1.5! Thesis Objectives
The overall goal of this thesis is to develop a non-invasive approach using hybrid
PET/MRI to improve EF localization, especially in MRI-negative epilepsy, as well as
assess structural integrity around EF, for improving DRE surgical evaluation. However,
the effect of quantitative PET biases from MRI-based attenuation correction on clinical
diagnosis of DRE was first assessed. Thus, our specific research objectives were to:
1) Assess the diagnostic equivalency and clinical value of PET/MRI against PET/CT
(current clinical standard for FDG-PET imaging) in DRE. This objective is the focus of
Chapter 2, which has been adapted from the following manuscript draft:
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Poirier SE, Kwan BYM, Jurkiewicz MT, Samargandy L, Iacobelli M, Steven DA, Lam
Shin Cheung V, Moran G, Prato FS, Thompson RT, Burneo JG, Anazodo UC, Thiessen
JD. An evaluation of the diagnostic competence of hybrid PET/MRI in clinical
management of drug-resistant epilepsy. Submitted to Am J Neuroradiol in June 2020.
Under Review. Manuscript ID: AJNR-20-00760
2) Develop a non-invasive approach combining FDG-PET and diffusion tractography
(PET/DTI) for assessing WM integrity around EF in the brains of MRI-negative DRE
patients. The potential clinical utility of our PET/DTI approach in epilepsy surgical
evaluation was also assessed. This objective is the focus of Chapter 3, which has been
adapted from the following manuscript publication:
Poirier SE, Kwan BYM, Jurkiewicz MT, Samargandy L, Steven DA, Suller-Marti A,
Lam Shin Cheung V, Khan AR, Prato FS, Burneo JG, Thiessen JD, Anazodo UC.
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F-

FDG PET-guided diffusion tractography reveals white matter abnormalities around the
epileptic focus in medically refractory epilepsy: implications for epilepsy surgical
evaluation. European J Hybrid Imaging. 2020;4:10. DOI: https://doi.org/10.1186/s41824020-00079-7
Finally, Chapter 4 provides a summary of the work presented in Chapters 2 and 3, and
also discusses some future directions for this research.
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Chapter 2!!

2!

An evaluation of the diagnostic competence of hybrid
PET/MRI in clinical management of drug-resistant
epilepsy

This chapter has been adapted from the following manuscript draft:
Poirier SE, Kwan BYM, Jurkiewicz MT, Samargandy L, Iacobelli M, Steven DA, Lam
Shin Cheung V, Moran G, Prato FS, Thompson RT, Burneo JG, Anazodo UC, Thiessen
JD. An evaluation of the diagnostic competence of hybrid PET/MRI in clinical
management of drug-resistant epilepsy. Submitted to Am J Neuroradiol in June 2020.
Under Review. Manuscript ID: AJNR-20-00760

2.1! Introduction
Approximately one in three epilepsy patients are diagnosed with drug-resistant epilepsy
(DRE) – seizures uncontrolled with anti-epileptic drugs – and may be considered for
surgical resection using an extensive surgical evaluation protocol, which includes
prolonged video-electroencephalography (VEEG) and MRI, to localize the seizure-onset
zone (SOZ).1,2 Absence of a clear lesion on MRI in about 25% of DRE patients is
common.3,4 The lack of a structural lesion significantly lowers a patient’s chances of
achieving long-term seizure freedom after surgery.5,6 In such cases, functional imaging
such as FDG-PET can be used to improve SOZ detection. Specifically, interictal FDGPET can indirectly locate the SOZ as brain regions showing decreased FDG uptake and
has been shown to aid detection of SOZ when MRI is negative or equivocal.1,7–9 FDGPET can resolve causative epileptic foci when multiple structural lesions are seen on
MRI10, as well as guide electrode placement in the brain during intracranial EEG (ICEEG) monitoring.7
Hybrid PET/MRI, the simultaneous acquisition of PET and MRI, has promising
applications in the clinical management of epilepsy.11,12 When PET is simultaneously
combined with MRI, the accuracy of localizing the SOZ is significantly improved7,10,13–15
and positive surgical outcomes can increase by up to 23%.7 Salamon et al. (2008)
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reported that in patients with focal cortical dysplasias, a common cause for apparently
MRI-negative epilepsy, co-registration of PET and MRI enhances lesion detection and
reduces the use of IC-EEG.13 What is more important is the promise PET/MRI holds in
further enhancement of PET quantification. MRI approaches for motion16 and partial
volume correction of PET17 show significant PET contrast enhancements which translate
to improvements in lesion localization and lateralization. Anatomical MRI-guided
approaches for non-invasive PET quantification may negate the need for standardized
uptake value (SUV) and move clinical PET towards parametric lesion characterization
and kinetic analysis of features hidden in SUV.18,19 These improvements in PET
combined with advanced multi-parametric MRI can revolutionize clinical management of
epilepsy.20
Despite the potential of hybrid PET/MRI, there have been concerns about its reliance on
MRI-based attenuation correction (MRAC) approaches, which have been shown to
produce biases in quantitative PET compared to traditional CT-based attenuation
correction (CTAC), particularly in the temporal and posterior aspects of the brain – areas
of the brain commonly implicated in DRE – prone to tissue misclassifications and high
inter-subject variability in bone density.21,22 However, few epilepsy studies have
investigated whether these biases have any effect on the diagnostic information provided
by PET/MRI relative to PET/CT. Previous reports have provided some preliminary
evidence that MRAC biases do not seem to affect the diagnostic accuracy of hybrid
PET/MRI in epilepsy23,24, but these studies lacked validation of PET/MRI and PET/CT
findings against gold standard post-surgical outcomes, such as histopathology.
Furthermore, new segmentation-based MRAC methods (such as RESOLUTE25) that aim
to improve bone tissue modelling especially around the base of the skull – a major
challenge of MRAC – have been shown to reduce MRAC PET biases in the human
brain.26 In this study, we evaluated the diagnostic equivalency and clinical value of
PET/MRI for epilepsy imaging against PET/CT, the current clinical standard for FDGPET imaging. SUVs and z-scores (number of standard deviations from the population
mean) were compared between PET/MRI and PET/CT to estimate regional MRAC bias,
particularly in brain regions often implicated in DRE. Diagnostic accuracy and sensitivity
of PET/MRI and PET/CT for SOZ detection were also compared using established
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reference standards (clinical hypothesis and histopathology, respectively) to assess the
potential clinical utility of hybrid PET/MRI in epilepsy surgical evaluation.

2.2! Materials and Methods
2.2.1!

Patients

This retrospective study initially consisted of 23 DRE patients recruited from the London
Health Sciences Centre epilepsy monitoring unit. Data from two patients were excluded
because of retrospective reconstruction failure of the FDG-PET data. Data from three
additional patients acquired after the scanner software upgrade were also excluded
because of MRAC compatibility issues. Thus, this study had a final sample size of 18
DRE patients (9 females, mean age = 37 ± 13 years). Presurgical evaluation included
patient history, physical examination, neuropsychological assessment, scalp VEEG, 1.5T
MRI, and PET/CT of the brain to localize the SOZ. A subset of the patients (n=10)
underwent surgical resection to remove the SOZ based on the clinical hypothesis,
determined through multi-disciplinary meetings at epilepsy surgical rounds. Surgical
outcome was assessed by evaluating degree of seizure freedom using the Engel
classification27 after a postoperative follow-up period of at least one-year. Patient
demographics, clinical profile, and surgical outcome are provided in Table 2.1. All
patients provided written informed consent and the study was approved by the University
Research Ethics Board.
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Table 2.1: Study patient demographics and surgical outcomes
Patient
#

Surgery
Histopathology
Performed
[Engel*]
1
M
32
2
1–2/day
R temp
Y [IIIA]
Gliosis
2
M
52
48
–
L temp-front
N
NA
3
M
29
13
4/week
L front
N
NA
4
F
18
4
1/month
R front
Y [IA]
GGM WHO I
5
M
60
19
6/year
L temp-front
N
NA
6
F
28
1
Unpredictable
R temp
Y [IIIA]
Gliosis
7
M
53
39
Unpredictable
L temp
N
NA
8
M
29
6
2–3/month
L temp-front
Y [IA]
Gliosis
9
F
32
7
–
L temp
N
NA
10
F
36
21
1/week
R front
Y [IIIA]
FCD Ib
11
F
45
10
5–7/month
L temp
Y [IA]
HS
12
M
23
2
1–2/month
R temp
Y [IV]
Gliosis
13
F
26
9
2–3/month
R temp-front
Y [IA]
Gliosis
14
M
23
17
3/month
L temp
Y [IA]
Gliosis
15
F
58
37
–
L temp
N
NA
16
F
38
31
–
R temp
N
NA
17
M
55
1
–
R temp
Y [IA]
Unremarkablea
18
F
33
12
1/week
L temp
N
NA
Note. Modified from a prior study33, where the sample size has now been increased from n=14 to n=18.
Abbreviations: –, missing data; F, female; FCD, focal cortical dysplasia; front, frontal lobe; GGM, ganglioglioma; HS, hippocampal
sclerosis; L, left; M, male; N, no; NA, not applicable; R, right; temp, temporal lobe; temp-front, temporal-frontal lobe; WHO, World
Health Organization grade; Y, yes.
*Surgical outcome was assessed one-year following surgery.
a
No specific structural changes that could explain the etiopathogenesis of patient’s epilepsy.

2.2.2!

Sex

Age
(yr)

Epilepsy
Duration (yr)

Seizure
Frequency

Clinical Hypothesis

Data Acquisition

The 18 DRE patients, who had a prior clinical 1.5T brain MRI scan using an epilepsy
protocol and had been referred for PET/CT, were scanned in a 3T hybrid PET/MRI
(Biograph mMR, Siemens Healthineers, Erlangen, Germany) immediately after clinical
PET/CT (Discovery VCT, GE Healthcare, Waukesha, WI) imaging. PET/MRI was
acquired ~40 min after intravenous bolus injection of 190 ± 16 MBq of

18

F-FDG and

patients had a fasting blood glucose of 4.3 ± 0.6 mmol/L. Structural MRI was acquired
during a 45 min list-mode PET imaging session and included; high resolution T1weighted MRI (1 mm3 isotropic voxels) acquired using a 3D magnetization-prepared
rapid gradient-echo sequence (MPRAGE), 3D T2-weighted FLAIR (1 mm3 isotropic
voxels) and the vendor-provided ultrashort echo time sequence for MRAC.
In order to compare PET images between PET/MRI and PET/CT negating potential
scanner biases, we reconstructed only PET images from the PET/MRI. PET images from
PET/MRI were corrected for scatter and decay while attenuation corrections were
performed using the RESOLUTE approach25 to generate PETMRAC images and using
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CTAC to generate PETCTAC images. Each patient’s CT images were first aligned and
transformed to the RESOLUTE MRAC maps using the expert automated registration
module in 3D Slicer28 (https://www.slicer.org/; Version 4.8), with custom combination of
6-parameter rigid and 12-parameter affine registration and normalized mutual
information as objective function. The patient bed and head holder were removed from
the CT images using a head mask generated from the RESOLUTE MRAC map. Volume
compensation was added from the RESOLUTE MRAC images to the CT slices in the
neck to account for the smaller CT field-of-view. CTAC maps were generated by
converting from CT Hounsfield units to linear attenuation coefficients for 511 keV
positron annihilation photons using the bilinear scaling approach.29 The 45-minute listmode PET data were reconstructed to one image volume (344 x 344 x 127 matrix) for
each attenuation correction type using Siemens e7 tools and an iterative algorithm
(ordered subset expectation maximization with point-spread function model; 3 iterations,
21 subsets, 3D Gaussian filter with a full-width at half-maximum of 2 mm, 2.09 x 2.09 x
2.03 mm3 voxel size, and zoom factor of 2.5).

2.2.3!

Qualitative Image Analysis

In order to assess the diagnostic competence of PET/MRI compared to PET/CT (current
clinical standard), PETMRAC, PETCTAC, 3T T1-weighted, and 3T T2-weighted images of
the 18 DRE patients were read by two neuroradiologists with over five and eight years of
clinical imaging experience, respectively. PETMRAC and PETCTAC were also read by a
nuclear medicine physician with over five years of clinical PET reading experience. The
three readers were aware of all clinical information while visually assessing patient FDGPET and MRI images. Images were visually inspected for quality and assessed for
evidence of brain abnormalities using syngo.via MI Neurology (Siemens Healthcare,
Erlangen, Germany). Rating scales were used to compare image quality, presence of
image artifacts, and extent of regional FDG-PET abnormalities on PETMRAC and PETCTAC
images. Image quality was assessed based on image smoothness, noise, resolution,
sharpness of contours and contrast-to-noise using the following rating scheme: 4 =
excellent; 3 = good; 2 = acceptable; and 1 = poor. Similarly, presence of image artifacts
was assigned to one of three categories: 3 = none; 2 = slight; or 1 = considerable. Lastly,
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extent of regional abnormalities on PETMRAC and PETCTAC was categorized using a
standard 4-point rating scale: 4 = normal; 3 = mildly decreased; 2 = moderately
decreased; and 1 = severely decreased.30 Diagnostic accuracy of PETMRAC and PETCTAC
for detecting the SOZ in the brain was qualitatively evaluated through comparison to a
reference standard. For this study, the reference standard was the clinical hypothesis
which was determined based on all available diagnostic information through
multidisciplinary meetings at epilepsy surgical rounds. Additionally, sensitivity of
PETMRAC and PETCTAC for SOZ localization was also assessed based on ground-truth
histopathological findings in DRE patients who underwent surgery (n=10).

2.2.4!

Region-Based Quantitative Assessment of PETMRAC and
PETCTAC

We assessed quantitative PETMRAC bias and its potential impact on epilepsy diagnosis by
comparing regional SUVs and z-scores between PETMRAC and PETCTAC using syngo.via
MI Neurology software with cerebellar normalization. MI Neurology is used in routine
clinical assessment to augment visual PET readings and quantify brain pathologies by
comparing individual patient PET scans against an age-appropriate normal database
(Scenium VD20).31 Mean SUVs and z-scores (Zdb) were compared between PETMRAC
and PETCTAC in thirty-six specific a priori brain regions often implicated in DRE.
To further quantify the agreement between PET/MRI and PET/CT, we used asymmetry
index (AI) mapping32, an automated data-driven approach, to non-invasively detect
hypometabolic brain regions (potential SOZ) and compared AI maps between PETMRAC
and PETCTAC. AI maps were generated as previously described.33 Mean and minimum zscore AI (ZAI) values were calculated in hypometabolic PET ROIs and compared
between PETMRAC and PETCTAC. The degree of overlap between PETMRAC and PETCTAC
ZAI ROIs was also assessed using the Dice similarity coefficient. Diagnostic accuracy and
sensitivity of PETMRAC and PETCTAC using AI mapping for SOZ detection were
determined based on the reference standard (clinical hypothesis) and histopathological
findings, respectively. All data analyses were conducted with knowledge of patient
clinical reports, diagnostic information, and post-surgical outcomes.
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2.2.5!

Statistical Analysis

For qualitative evaluation of PETMRAC and PETCTAC images, we assessed inter-reader
agreement between the three clinical readers using Randolph’s free-marginal multirater
kappa test (http://justusrandolph.net/kappa/), where a value $ 0.70 indicates adequate
agreement. For quantitative FDG-PET assessment, we used Pearson product-moment
analysis to determine the correlation in SUV as well as Zdb across all brain regions
between PETMRAC and PETCTAC. We used Bland-Altman analysis to assess brain SUV
and Zdb bias between modalities. Additionally, we used the two-sample t-test to compare
regional mean SUV between PETMRAC and PETCTAC. For all analyses, p < 0.05
(uncorrected) was considered statistically significant.

2.3! Results
Visual assessment of PETMRAC and PETCTAC revealed similar SUVMRAC and SUVCTAC
images in all 18 DRE patients, as illustrated in a representative patient (patient #2) in
Figure 2.1. Interestingly, in this patient, although visual readings were comparable
between modalities, the PETMRAC Zdb images were slightly exaggerated relative to the
PETCTAC (Figure 2.1B). However, all three readers reached the same clinical outcome on
PETMRAC and PETCTAC. In all 18 patients, inter-reader agreement for visual assessment
was similar between PETMRAC and PETCTAC (overall agreement = 78% and 81%,
respectively; kappa = 0.70 and 0.75, respectively). Compared to 1.5T MRI, 3T MRI
revealed 50% more structural lesions. Positive lesions were identified in 5/18 (28%)
patients on 1.5T MRI and 12/18 (67%) patients on 3T MRI.
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Figure 2.1: Comparison of visual PET assessment between PETMRAC and PETCTAC in an
MRI-negative epilepsy patient (patient #2). A) SUV images are well matched between
PETMRAC and PETCTAC. B) Z-score maps show exaggerated regional hypometabolism
(especially in the left temporal lobe) in PETMRAC. C) Slices of percent difference SUV
(!SUV) map show low quantitative bias between PETMRAC and PETCTAC.

Quantitative PET analysis revealed a strong correlation in mean SUV (r = 0.99, p <
0.001) and mean Zdb (r = 0.92, p < 0.001) between modalities across all brain regions in
the 18 DRE patients with low SUV and Zdb biases (0.35 ± 0.30 and -0.05 ± 0.64
respectively), suggesting PETMRAC provided similar metabolic information as PETCTAC
(Figure 2.2). Regional mean SUV was well matched between PETMRAC and PETCTAC (p
> 0.05). Similarly, strong correlations in mean SUV and Zdb were also observed in
specific brain regions included in visual clinical readings (Table 2.2). In these brain
regions, overall inter-reader agreement, kappa values, mean SUV and mean Zdb were all
comparable between PETMRAC and PETCTAC.
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Figure 2.2: Association between PETMRAC and PETCTAC across all brain regions in 18
DRE patients. A) Regression plots show a tight correlation in mean SUV (r = 0.99, p <
0.001) and mean Zdb (r = 0.92, p < 0.001) between modalities. B) Bland-Altman plots
reveal close agreement in SUV (bias: -0.23 to 0.93) and Zdb (bias: -1.31 to 1.21) between
PETMRAC and PETCTAC.
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Table 2.2: Qualitative and quantitative regional assessments of diagnostic
competency between PETMRAC and PETCTAC
Region

PET AC

Pearson r
(SUV)
0.99

Pearson r
(Zdb)
0.91

Mean SUV
(g/mL)
Frontal
MRAC
8.08 ± 2.17
CTAC
8.43 ± 2.23
Temporal
MRAC
0.99
0.96
7.95 ± 2.08
CTAC
8.34 ± 2.15
Parietal
MRAC
0.99
0.97
8.33 ± 2.25
CTAC
8.69 ± 2.32
Hippocampus
MRAC
0.99
0.95
5.67 ± 1.57
CTAC
5.85 ± 1.60
Occipital
MRAC
0.99
0.97
8.71 ± 2.32
CTAC
9.09 ± 2.40
Cerebellum
MRAC
0.99
0.84
6.52 ± 1.75
CTAC
6.96 ± 1.86
Note. SUV and Z-score values are reported as mean ± standard deviation.

Mean Zdb
-1.10 ± 1.08
-1.20 ± 1.12
-0.85 ± 1.49
-0.83 ± 1.53
-0.55 ± 1.33
-0.68 ± 1.28
-0.59 ± 1.67
-0.83 ± 1.76
0.96 ± 1.59
0.83 ± 1.52
-2.18 ± 1.91
-1.60 ± 1.95

Inter-reader
agreement (%)
81
85
56
56
88
92
64
69
94
98
82
86

Kappa
0.75
0.80
0.41
0.41
0.84
0.90
0.52
0.58
0.92
0.97
0.76
0.82

In thirty-six a priori brain regions commonly implicated in DRE, mean SUV and Zdb
values were similar between PETMRAC and PETCTAC (Figure 2.3). Most notably, regional
MRAC SUV and Zdb biases were low (<5% and <0.5, respectively) in all a priori brain
regions, except for inferior aspects of the brain (Figure 2.4).

35

Figure 2.3: Mean SUV and Zdb values (n=18) in thirty-six a priori brain regions often
interrogated in DRE. MRAC and CTAC produce similar mean SUV, Zdb and in most
cases matched outliers (black dots) across all brain regions (p > 0.05).
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Figure 2.4: Group percent difference in SUV (left) and absolute difference in Zdb (right)
between PETMRAC and PETCTAC in thirty-six a priori brain regions often interrogated in
DRE. Error bars indicate standard deviation. Mean MRAC SUV and Zdb biases across all
thirty-six a priori brain regions were -4.02 ± 2.03% and 0.35 ± 0.27, respectively. Most
brain regions have <5% SUVMRAC bias or <0.5 Zdb-MRAC bias except regions in lateral
aspects at the base of the skull (denoted with an *). Abbreviations: cb, cerebellum; front,
frontal lobe; fg, fusiform gyrus; gr, gyrus rectus; Hg, Heschl’s gyrus; hipp, hippocampus;
itg, inferior temporal gyrus; ins, insula; mtl, mesial temporal lobe; mtg, middle temporal
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gyrus; occ, occipital lobe; phg, parahippocampal gyrus; par, parietal lobe; stg, superior
temporal gyrus; temp, temporal lobe; tp:mtg, temporal pole: middle temporal gyrus;
tp:stg, temporal pole: superior temporal gyrus; thal, thalamus.

A summary of the qualitative and quantitative findings comparing the diagnostic
competency of PETMRAC and PETCTAC are provided in Table 2.3. Image quality, presence
of image artifacts, visual PET assessment, and diagnostic accuracy all showed good
agreement and were comparable between modalities. In the ten patients who underwent
surgery, sensitivity of both PETMRAC and PETCTAC in detecting the SOZ was 83% (visual)
and 70% (AI). In all 18 patients, ZAI maps had high similarity between modalities (mean
Dice coefficient = 0.88 ± 0.08), as illustrated in a representative patient (patient #11) in
Figure 2.5.
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Table 2.3: Qualitative and quantitative assessments of diagnostic competency
between modalities
PETMRAC
PETCTAC
Diagnostic accuracy (visual)
87%
85%
Diagnostic accuracy (AI)
78%
78%
Sensitivity (visual; n=10)
83%
83%
Sensitivity (AI; n=10)
70%
70%
Image quality agreement (kappa)
92% (0.89)
92% (0.90)
Image artifact agreement (kappa)
83% (0.75)
88% (0.82)
Visual PET agreement (kappa)
78% (0.70)
81% (0.75)
Mean ZAI
-2.54 ± 0.41
-2.56 ± 0.42
Minimum ZAI
-4.40 ± 1.22
-4.38 ± 1.21
Dice coefficient (AI) = 0.88 ± 0.08
Note. Visual PET agreement is the average concordance in visual PET readings across all
brain regions between the three clinical readers. Visual PET readings were augmented
with quantitative PET (Zdb). Mean and minimum ZAI values are reported as mean ±
standard deviation.

Figure 2.5: Visual assessment reveals similar A) attenuation correction, B) SUV, C) Zdb
and D) ZAI maps (L < R) between PETMRAC and PETCTAC in one DRE patient (patient
#11).
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2.4! Discussion
This study assessed the potential clinical value of hybrid PET/MRI in epilepsy imaging
for DRE surgical evaluation by first evaluating the diagnostic equivalency of qualitative
and quantitative PET/MRI against the clinical standard PET/CT and post-surgical
outcomes. Visual assessments of PET/MRI and PET/CT were similar and yielded
comparable diagnostic outcome in our DRE patient cohort. Likewise, the quantitative
bias between PETMRAC and PETCTAC was low and of no practical significance.
Other studies have attempted to evaluate the clinical value of hybrid PET/MRI in
DRE.11,12,23,34,35 For example, Shang et al. (2018) assessed concordance between ASLMRI and FDG-PET in MRI-negative epilepsy, but did not compare metabolic findings to
the clinical standard PET/CT.12 Shin et al. (2015) aimed to evaluate the potential added
value of 3T hybrid PET/MRI in localizing the epileptic focus in DRE compared to
standalone 1.5T MRI and PET/CT, however, PET/CT was acquired in only 40% of
patients and use of PET/MRI was not evaluated against IC-EEG and post-surgical
outcomes.35 Similarly, other studies such as Boscolo-Galazzo et al. (2016), Ding et al.
(2014) and Paldino et al. (2017) that attempted to assess concordance between PET/MRI
and PET/CT findings in DRE also lacked validation against post-surgical outcomes, most
notably gold-standard histopathology.11,23,34 Thus, our study, by comparing PET findings
to post-surgical and histopathology outcomes, appears to be the first to comprehensively
demonstrate the potential clinical utility of hybrid PET/MRI in epilepsy imaging using a
recently optimized MRAC approach.
The advantages of hybrid PET/MRI in epilepsy extend beyond co-registration and cointerpretation of PET and structural MRI to co-localization of PET with advanced
functional MRI and structural connectivity techniques such as diffusion tractography
imaging.33 Recently, several groups have already shown promising first results when
assessing patients with epilepsy using simultaneous PET/MRI.11,34,35 These studies
focused on localization of SOZ using conventional structural MRI and qualitative visual
FDG-PET assessments. While it is not yet fully known if combined quantitative PET and
MRI can provide higher rates of SOZ localization compared to qualitative cointerpretation of PET and MRI, one study has shown that quantitative PET can improve
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confidence of a clinical reader’s visual assessment of PET.11 As demonstrated here,
although quantitative PET/MRI using an existing normal PET/CT database to augment
visual assessments can be limited, these limitations may be compensated for using other
semi-quantitative approaches, such as AI mapping when a normal database is not
available or suitable, for example in pediatrics.11,32 Because AI mapping compares
glucose metabolism between hemispheres within individual patients, it may be less
sensitive to the attenuation correction approach and could be a promising tool for
assessing PET/MRI abnormalities in epilepsy, especially if comparison of AI values
between patients and healthy controls are used.
Although we found that regional mean SUVs were well matched across brain regions,
biases in mean SUV from PET/MRI of up to 10% can occur in brain regions at the base
of the skull where there is greater variability in bone densities and higher proportion of
mixed tissue signals such as the inferior temporal gyrus, temporal pole, and cerebellum.
This SUV underestimation is most likely related to inadequate tissue classification in
MRAC approaches, a challenge for MRI, given that bone and air in sinuses both appear
black on MRI and can be challenging to distinguish. While these MRAC errors further
bias quantitative PET and could limit the clinical adoption of hybrid PET/MRI for
epilepsy imaging, we have demonstrated in our study the diagnostic equivalency of
PET/MRI to PET/CT, suggesting that these MRAC biases do not seem to affect the
overall clinical impression provided by PET/MRI, a finding that is consistent with past
studies.23,24 Nevertheless, if PET/MRI in conjunction with quantitative PET evaluation
(such as syngo.via MI Neurology) is to be used for improving SOZ localization, then
further improvements in MRAC as well as consideration of practical issues related to
PET/MRI scanning such as inaccurate compensation for head pads and the use of
headphones36, are still required before the use of these novel technologies can be
recommended as clinical standard of care. It is expected that improvements in brain tissue
classification and bone modelling from novel machine learning approaches37 will further
improve PET/MRI performance at the base of the skull, potentially reducing the MRAC
biases observed in this study.
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Although we have demonstrated the diagnostic equivalency of PET/MRI to PET/CT in
this study, the potential added value of hybrid PET/MRI in epilepsy imaging above and
beyond the current clinical standard – PET/CT and 1.5T/3T MRI – is still yet to be fully
investigated. It is apparent that 3T MRI provides a clear advantage over 1.5T MRI for
anatomical localization of DRE as demonstrated here and reported elsewhere.35 However,
the added value of simultaneous acquisition of PET/3T MRI in providing
pharmacokinetic modeling of PET38, as well as novel iterative partial volume and motion
correction algorithms that use MRI to improve PET resolution39 have not been explored
in DRE, particularly in MRI-negative epilepsy. Recently, Poirier et al. (2020) used AI
mapping of FDG-PET to guide diffusion tractography of white matter fiber pathways
around hypometabolic brain regions, revealing macrostructural breakdown around SOZ
in MRI-negative DRE.33 While the clinical significance of hybrid PET/MRI in epilepsy
surgical evaluation is still yet to be fully characterized, the potential for hybrid PET/MRI
is evident.

2.5! Conclusions
Although PET/MRI has been advocated as standard of care for epilepsy imaging, the
performance of PET/MRI compared to PET/CT or its clinical value for epilepsy imaging
has not been fully established. This study demonstrated the diagnostic equivalency and
clinical value of hybrid PET/MRI in epilepsy imaging against the current clinical
standard of care. In general, PET/MRI with optimal MRAC can yield similar diagnostic
performance as PET/CT. Further improvements in MRAC as well as novel approaches
using fully quantitative PET analysis are likely necessary to evaluate the potential added
value of hybrid PET/MRI in epilepsy before widespread clinical adoption of hybrid
PET/MRI in DRE surgical evaluation can take place.
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F-FDG PET-guided diffusion tractography reveals white
matter abnormalities around the epileptic focus:
implications for epilepsy surgical evaluation

This chapter has been adapted from the following manuscript publication:
Poirier SE, Kwan BYM, Jurkiewicz MT, Samargandy L, Steven DA, Suller-Marti A,
Lam Shin Cheung V, Khan AR, Prato FS, Burneo JG, Thiessen JD, Anazodo UC. 18FFDG PET-guided diffusion tractography reveals white matter abnormalities around the
epileptic focus in medically refractory epilepsy: implications for epilepsy surgical
evaluation. European J Hybrid Imaging. 2020;4:10. DOI: https://doi.org/10.1186/s41824020-00079-7

3.1! Introduction
Medically refractory epilepsy (MRE) affects approximately 30% of epilepsy patients and
is defined as a chronic neurological disorder where seizures persist despite administration
of anti-epileptic drugs (AEDs) (Helmstaedter et al. 2003; Richardson et al. 2004; Jiang et
al. 2017). In some MRE patients, surgical resection of the epileptic focus (EF) – the brain
region responsible for seizures – can alleviate seizure occurrence and improve overall
quality of life (Richardson et al. 2004; Caciagli et al. 2014; Cahill et al. 2019). Positive
surgical outcomes are highly dependent on accurate identification of the EF to ensure the
epileptic region is safely removed without harming surrounding healthy brain tissue
(Bettus et al. 2009). The current gold standard for identifying the EF is intracranial
electroencephalography (IC-EEG), where either subdural or depth electrodes are used to
directly locate abnormal brain activity (suspected EF) before surgical resection is
performed (Knowlton 2006; Blount et al. 2008). However, about 50% of MRE patients
continue to have seizures after surgery (Téllez-Zenteno et al. 2005; de Tisi et al. 2011).
Surgery can fail to prevent seizures when the EF is not properly delineated or detected
prior to resection. Additionally, poor surgical outcomes can occur due to unknown
interactions between the EF and surrounding neural networks (Aparicio et al. 2016).
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Recent advances in medical imaging have seen the increased clinical use of magnetic
resonance imaging (MRI) and positron emission tomography (PET) to non-invasively
locate the EF and map out the structure and function of surrounding brain regions.
Anatomical MRI can detect structural lesions responsible for seizures in about 60% of
MRE patients (Burneo et al. 2015), while other advanced MRI techniques, such as
diffusion tensor imaging (DTI), can be used to effectively characterize the EF and its
relationships with surrounding brain regions (Aparicio et al. 2016; Jiang et al. 2017). DTI
non-invasively characterizes tissue microstructure by providing a three-dimensional
model of water diffusion in the brain (Basser and Jones 2002; Jones and Cercignani
2010). In addition, DTI can be used to investigate the structural connectivity of neural
networks through mapping out diffusion along white matter (WM) fiber pathways (Le
Bihan et al. 1986; Le Bihan 2006; Aparicio et al. 2016; Sivakanthan et al. 2016). WM
pathways can be characterized using DTI-derived parameters, which are extracted from
the diffusion tensor used to model water diffusion at each voxel in the brain. The most
commonly used tensor-derived scalar is fractional anisotropy (FA), which is a measure of
WM integrity and describes the tendency of water to preferentially diffuse along the
length of the fiber bundle (Le Bihan 2006; Mori and Zhang 2006; Soares et al. 2013).
Recent DTI studies have revealed that severe FA reduction in WM may correspond to
widespread microstructural abnormalities in MRE (Labate et al. 2015; Jiang et al. 2017).
To further assess tissue microstructure breakdown, WM pathways can be visualized by
reconstructing WM fibers using diffusion tractography. Diffusion tractography
techniques continue to be refined and adapted for neurosurgical planning and these
techniques have been shown to accurately track WM fibers in temporal lobe regions
essential for surgical success (Sivakanthan et al. 2016).
PET, on the other hand, is the most sensitive non-invasive clinical tool for identifying the
EF especially in cases where MRI is negative or equivocal (Burneo et al. 2015).
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F-

Fluorodeoxyglucose PET (FDG-PET) can be used to detect the EF as brain areas
showing decreased glucose uptake (glucose hypometabolism) (Sarikaya 2015; Burneo et
al. 2015; Aparicio et al. 2016; Cahill et al. 2019). Glucose hypometabolic regions of
interest (ROIs) are often identified by visual assessment of FDG-PET images, however,
some abnormalities may be missed during this process. Therefore, semi-quantitative
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approaches such as asymmetry index (AI) mapping have been proposed to aid visual
detection of hypometabolic PET ROIs (Henry et al. 1990; Rausch et al. 1994; Van
Bogaert et al. 2000; Didelot et al. 2010; Boscolo Galazzo et al. 2016; Anazodo et al.
2018; Kamm et al. 2018; Shang et al. 2018). AI mapping investigates metabolic
abnormalities by measuring the voxel-wise difference in cerebral glucose metabolism
between hemispheres and has been shown to be a very sensitive biomarker for
epileptogenicity (Didelot et al. 2010; Boscolo Galazzo et al. 2016). Using AI to
investigate metabolic asymmetries can be useful because the process may be done on
individual patients and does not require comparison to a healthy control database.
Recently, it has been shown that multimodal brain imaging combining PET and MRI
information may improve seizure site characterization compared to standalone IC-EEG,
PET, or MRI (Burneo et al. 2015). Opportunely, this finding coincides with increased
availability of advanced imaging systems that combine PET/MRI into an integrated
system. Although researchers are starting to implement simultaneous PET/MRI in the
clinical setting, the combined use of PET and DTI for presurgical evaluation of epilepsy
is yet to be fully investigated. To our knowledge, only two studies to date have assessed
whether cortical glucose hypometabolism seen on FDG-PET is related to WM alterations
identified by DTI in the brains of MRE patients (Lippé et al. 2012; Aparicio et al. 2016).
However, these studies acquired PET and MRI scans at separate timepoints which can
introduce registration errors between modalities, making it difficult to accurately detect
the seizure onset zone in the brain and assess relationships between PET and MRI
findings. Simultaneous acquisition of PET and MRI data using a hybrid PET/MRI
scanner acquires both datasets in the same imaging session with intrinsic spatial and
temporal registration, potentially improving the accuracy of detecting the EF and may
shed new insight into the pathophysiology of MRE. In this hybrid PET/MRI study, we
developed a PET-guided diffusion tractography (PET/DTI) approach combining FDGPET and diffusion MRI to investigate WM integrity in the brains of MRE patients. AI
mapping of FDG-PET was used to guide diffusion tractography of WM tracts in MRE
patients to better understand structural connectivity of WM fibers affected by glucose
hypometabolic regions (suspected EF). WM fibers were also visually inspected by a
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neurologist to assess potential clinical impact of PET/DTI on decision-making in epilepsy
surgery.

3.2! Materials and Methods
3.2.1!

Patients

The study included 14 MRE patients (6 males and 8 females; mean age = 38 ± 14 years)
from the London Health Sciences Centre epilepsy monitoring unit (EMU), diagnosed
after failing two or more adequate trials of AEDs. Clinical assessment in the EMU
included neuropsychological evaluation, prolonged scalp video-EEG, and 1.5T MRI to
localize the EF. Patient demographics and clinical profile are provided in Table 3.1.
Mean epilepsy onset and duration was 23 ± 13 and 15 ± 15 years, respectively. The
cohort consisted of 10 MRI-negative and 4 MRI-equivocal MRE patients, determined
based on all available diagnostic information (clinical hypothesis, semiology, and 1.5T
MRI reports). All patients provided written informed consent. The study was approved by
the University Research Ethics Board and conducted in accordance with the Declaration
of Helsinki ethical standards.
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Table 3.1: Patient demographics and clinical profile
Patient
No.
1

Sex

Age (yr)

Seizure
Frequency
–

1.5T MRI

Clinical Hypothesis

52

Onset/
Duration (yr)
4/48

M

Left MTS*

Left temporal-frontal lobe

2

M

29

16/13

4/wk

Left temporal FCD*

Left frontal lobe

3

F

18

14/4

1/mo

Unremarkable

Right frontal lobe

4

M

60

41/19

6/yr

Unremarkable

Left temporal-frontal lobe

5

F

28

27/1

Unpredictable

Unremarkable

Right temporal lobe

6

M

29

23/6

2–3/mo

Unremarkable

Left temporal-frontal lobe

7

F

32

25/7

–

Unremarkable

Left temporal lobe

8

F

36

15/21

1/wk

Bitemporal SH*

Right frontal lobe

9

F

45

35/10

5–7/mo

Left MTS*

Left temporal lobe

10

M

23

21/2

1–2/mo

Unremarkable

Right temporal lobe

11

F

26

17/9

2–3/mo

Unremarkable

Right temporal-frontal lobe

12

F

58

21/37

–

Unremarkable

Left temporal lobe

13

F

38

7/31

–

Unremarkable

Right temporal lobe

14

M

55

54/1

–

Unremarkable

Right temporal lobe

Abbreviations: *, equivocal finding; –, missing data; F, female; FCD, focal cortical dysplasia; M, male; MTS, mesial temporal sclerosis; SH,
subcortical heterotopia.

3.2.2!

Data Acquisition

Data were acquired using a 3T hybrid PET/MRI scanner (Biograph mMR, Siemens
Healthineers, Erlangen, Germany) located at the Lawson Health Research Institute.
Patients fasted for at least 6 h prior to the study (fasting blood glucose = 4.3 ± 0.6
mmol/L). PET/MRI were acquired immediately after clinical PET/CT scans (net injected
dose of FDG = 190 ± 17 MBq, PET/MRI post-injection time = 72 ± 5 minutes) and the
PET/MRI data were used in this study. Serial MRI scans were performed during a 30-min
list-mode PET imaging session. An isotropic (1 mm3) high resolution T1-weighted MRI
and T2-weighted FLAIR MRI were acquired covering the whole brain using a threedimensional magnetization-prepared rapid gradient-echo sequence (MPRAGE) and fastspin echo sequence (SPACE) respectively to assess evidence of structural abnormalities
(Brant-Zawadzki et al. 1992). Diffusion-weighted imaging (DWI) was acquired using a
single shot echo-planar imaging (EPI) sequence with the following parameters: 2 mm
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isotropic resolution, 64 contiguous slices, b-values = 0, 1000 s/mm2 and 64 diffusion
encoding directions. Two spin-echo images were acquired in opposite phase-encoding
directions with b-values = 0 s/mm2 and 6 directions to correct for inherent susceptibilityinduced distortions in DWI. The PET data were reconstructed to one image volume
(ordered subset expectation maximization algorithm; 3 iterations, 21 subsets, 2 mm fullwidth at half-maximum (FWHM) Gaussian filter, 2.5 zoom factor, 344 % 344 % 127
matrix and 2.09 % 2.09 % 2.03 mm3 voxels). Attenuation correction was performed using
an ultrashort echo time MRI sequence and an offline MRI-based attenuation correction
approach (RESOLUTE) (Ladefoged et al. 2015).

3.2.3!

DWI Preprocessing

Before image preprocessing, all DWI volumes were visually inspected for artifacts to
ensure only good quality data were used. DWI data were preprocessed using an in-house
image analysis pipeline that incorporated steps from a variety of different image
processing software packages (see Figure 1.7). Each patient’s DWI images were first
denoised using an optimized non-local means filter (Wiest-Daesslé et al. 2008; Coupé et
al. 2008, 2010) in MATLAB (MathWorks®, Natick, MA) followed by subject motion,
eddy current, and bias field corrections using FMRIB’s Software Library (FSL)
(Woolrich et al. 2009), MRtrix3 (Tournier et al. 2019) and ANTS (Avants et al. 2011),
respectively. Tensors were fit to the data using non-linear least-squares estimation in
ExploreDTI (Leemans et al. 2009) to generate an FA map. For WM fiber reconstruction,
all diffusion tractography steps were performed using MRtrix3. A single fiber WM
response function was estimated from the preprocessed DWI data using a spherical
harmonics order of 8. The DWI data were upsampled to 1x1x1 mm3 isotropic voxels, and
the fiber orientation distribution function was calculated by constrained spherical
deconvolution with a spherical harmonics order of 8 and a whole-brain mask to constrain
calculations to voxels within the brain. The maximas of the fiber orientation distribution
function were then extracted and used to visualize the WM fibers.
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3.2.4!

PET Data Analysis

PET preprocessing steps were completed using FSL, ANTS and SPM12 (Wellcome
Department of Cognitive Neurology, Institute of Neurology, London). For AI mapping,
we used the MNI T1 1 mm isotropic image provided by FSL as a template for spatial
alignment of patient FDG-PET images. To account for geometric distortions in patient
anatomy between hemispheres, this template was made symmetric by flipping it about
the sagittal plane and then calculating the mean image of the flipped and unflipped
images. Each patient’s FDG-PET data were spatially normalized to the symmetric
template using a three-step registration method in ANTS that consisted of linear and nonlinear warping transformations that aligned brain structures in the PET image as closely
as possible to the template.
A voxel-wise standardized uptake value (SUV) map was calculated using:
SUV!=

CPET (t)!× BW
Dose

where CPET (t) is the activity concentration in each voxel of the spatially normalized PET
image, BW is the patient’s body weight, and Dose is the net injected dose of FDG. The
SUV map was smoothed using a FWHM of 2 mm to account for differences in patient
anatomy. Each patient’s T1-weighted image was spatially normalized to the symmetric
MNI template and then segmented into gray matter (GM), WM, and cerebrospinal fluid
tissue probability maps. Because the EF is typically in GM focal regions, we only
considered SUV values in voxels with at least 30% GM (based on segmentation of the
aligned T1-weighted MRI). The GM SUV maps were then scaled by the individual mean
GM SUV in the cerebellum to account for global metabolism effects in the brain
(Anazodo et al. 2018). The relative GM SUV (SUVr) map was spatially flipped about the
sagittal plane and a voxel-wise AI map was calculated using:
AI!=

I!-!fI
× 100
2(I!+!fI)
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where I and fI are the unflipped and flipped SUVr images, respectively. To determine
significant hypometabolic areas on PET, a Z-score AI (ZAI) map was calculated using:
ZAI !=

X!- µ
σ

where X is the voxel intensity in the AI map, µ is the mean AI of all GM voxels in the
brain, and σ is the standard deviation AI of all GM voxels. Because we did not know the
exact distribution of AI values in our sample of patients, we scaled ZAI by the degrees of
freedom (df) in our sample (Crawford and Garthwaite 2012). For our sample of 14 MRE
patients, df was 13 therefore we considered ZAI < -1.77 to represent significant
hypometabolism compared to the contralateral brain region. In each ZAI map, the largest
focal GM area containing voxels with ZAI < -1.77 was extracted as the hypometabolic
PET ROI (suspected EF). To validate our AI mapping approach, these PET ROIs were
compared against clinical findings on seizure onset area, including clinical hypothesis,
scalp video-EEG, clinical reader assessment of PET SUV images, stereo-EEG (SEEG),
and surgical outcome (Engel classification and ground-truth histopathology).

3.2.5!

PET/MR Image Reading

All FDG-PET and MR images were visually inspected by two Neuroradiologists
(B.Y.M.K. and M.J.). FDG-PET was also inspected by a third reader, a Nuclear Medicine
Physician (L.S.). FDG-PET was co-registered and overlaid onto MRI. T1-weighted, T2weighted, and SUV images were visually assessed using a standard clinical imaging
software (MI Neurology, SyngoVia, Siemens Healthcare, Erlangen, Germany). To aid
visual assessment of PET, semi-quantitative analysis was also included in the image
reading through statistical comparison of SUV values with cerebellar normalization to an
age-matched healthy control database provided by the software.

3.2.6!

PET-Guided Diffusion Tractography (PET/DTI)

We developed a PET/DTI approach by using seed-based diffusion tractography to
investigate structural integrity of WM regions around the hypometabolic PET ROI
(suspected EF) identified by AI mapping. The PET ROI, which was initially defined in
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MNI space, was inverse mapped back to the subject’s diffusion space and used as a seed
to initiate fiber tracking. WM fiber tracts were visualized and quantified using
Fibernavigator, a novel diffusion tractography tool (Chamberland et al. 2015). In
Fibernavigator, a 3x3x3 mm3 volume of interest (VOI) was placed in the GM PET ROI
that was directly adjacent to the closest WM area. This VOI was dilated at incremental
distances of 3, 9, and 15 mm into surrounding WM (Figure 3.1). Each dilated VOI was
used as a seed region to generate WM tracts at each distance from the PET ROI. Another
3x3x3 mm3 VOI was manually defined in the contralateral brain region and dilated to
generate fibers for the same three distances into surrounding WM. To assess WM tract
asymmetry between ipsilateral and contralateral WM fiber tracts, WM fiber
quantification was performed by extracting measurements readily available in
Fibernavigator, such as fiber count (number of fibers within the bundle), mean fiber
length (mm), and mean fiber cross-section (CS) (mm2). In addition, the mean FA was
calculated as the weighted average of all FA values along the length of the tracts.
Normalized (ipsilateral / contralateral) fiber count, mean FA, mean fiber length, and
mean CS measurements served as preliminary assessments of WM tract asymmetry and
the Wilcoxon signed-rank test was then used to compare fiber measurements across the
three WM distances from the PET ROI (p < 0.05 was considered significant).
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Figure 3.1: 2D representation of the 3D procedure for tracking WM regions around the
EF in one MRE patient (patient #9). A) EF (detected by AI mapping of FDG-PET)
overlaid onto structural MRI. B) EF overlaid onto a WM probability map. Because the
EF is located in a cortical area (left hippocampus), WM tracking was performed at three
distances away from the EF: 3 mm, 9 mm, and 15 mm. The coloured regions around the
EF represent WM areas covering the three distances. These WM regions were used as
seed ROIs to initiate neural fiber bundle tracking in Fibernavigator.

3.2.7!

Clinical Assessment of PET/DTI Findings

WM fibers around the hypometabolic PET ROI for each patient were visualized by a
senior Neurologist with over 15 years of practice experience (J.G.B.) in order to assess
the potential clinical impact of the PET/DTI approach in guiding epilepsy surgical
evaluation. For each patient, the neurologist first viewed the summary of presurgical
evaluation findings (clinical hypothesis, scalp video-EEG, 1.5T MRI, PET report from
PET/CT, SEEG) and then using Fibernavigator, interactively viewed the ipsilateral and
contralateral WM fibers 3 mm away from the hypometabolic PET ROI identified by AI
mapping. A distance of 3 mm away from the PET ROI was chosen for this assessment, as
WM fibers generated from this distance pass directly adjacent to the GM PET ROI and
are likely to give the best indicator of structural integrity around the epileptic zone. For
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the clinical assessment of the PET/DTI approach, the neurologist determined whether the
differences between ipsilateral and contralateral WM fibers around the hypometabolic
PET ROI (suspected EF) were concordant with the clinical hypothesis. In order to assess
potential clinical impact of PET/DTI, the neurologist’s confidence after viewing the WM
fibers was assigned to one of the following categories: unchanged or improved. If
confidence was improved, the neurologist also reported if reassessment of surgical
candidacy would be beneficial in patients who had not undergone surgery.

3.3! Results
3.3.1!

AI Mapping of FDG-PET for EF Localization and
Lateralization in MRE

AI mapping was used to detect the EF based on regions showing significant metabolic
asymmetry between hemispheres in the brain. A visual example of the AI mapping
results for one MRE patient (patient #9) is shown in Figure 3.2. In this patient, AI
mapping was able to detect a clear hypometabolic region (suspected EF) in the left
temporal lobe, which matched the overall clinical hypothesis.
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Figure 3.2: Images from a 45 year old female MRE patient (patient #9) with a clinical
hypothesis of left temporal lobe focal epilepsy: A) PET SUV map; B) Anatomical MRI;
C) PET fused with MRI; D) Z-score map from computer-assisted diagnosis of PET data
(Siemens Syngo Via); E) Z-score map generated from AI mapping (ZAI map), which
shows a clear glucose hypometabolic region (green circle) in the left temporal lobe,
indicative of a potential EF; and F) hypometabolic PET ROI (yellow) from AI mapping
overlaid onto structural MRI.

Clinical

hypothesis,

scalp

video-EEG

findings

from

the

EMU,

FDG-PET

hypometabolism reports from the three clinical readers (3T MRI visual assessment
reported in Table S1), AI mapping, SEEG, and surgical findings for our cohort of 14
MRE patients are summarized in Table 3.2. AI mapping findings were concordant with
the clinical hypothesis in localizing and lateralizing the epileptic region in 12/14 (86%)
and 9/14 (64%) patients, respectively. AI mapping agreed with scalp video-EEG in 13/14
(93%) patients for both EF localization and lateralization. Concordance between AI
mapping and clinical PET readings was 64%/69% (average EF localization/lateralization
from the three clinical readers). Five patients underwent SEEG prior to surgical resection,
and EF localization/lateralization concordance with AI mapping was observed in four
patients. Mean SUV, max SUV, and mean ZAI were decreased in hypometabolic PET
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ROIs identified by AI mapping (see Table S2). Eight patients underwent surgical
resection to remove the EF on the suspected epileptogenic side based on all clinical
information and diagnoses available. After a one-year follow-up, 5/8 (62.5%) patients
achieved Engel class IA (long-term seizure freedom), 2/8 (25%) patients achieved Engel
class IIIA (significant improvement, but not completely seizure free), and 1/8 (12.5%)
patients had Engel class IV (no improvement). AI mapping was concordant with surgical
findings, where histopathology was performed to determine the ground-truth EF
classification, in localizing and lateralizing the EF in six and four patients, respectively.
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Note. FDG-PET hypometabolism reports from three clinical readers are summarized under the headings PET R1, PET R2, and PET R3.
Abbreviations: FCD, focal cortical dysplasia; front, frontal lobe; GGM, ganglioglioma; L, left; par, parietal lobe; Pt, patient; R, right; temp, temporal lobe; WHO, World Health Organization grade.
a
No specific structural changes that could explain the etiopathogenesis of patient’s epilepsy.
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Table 3.2: EEG, PET, and surgical findings
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3.3.2!

PET/DTI – Tracking WM Around Glucose Hypometabolic
Regions (Suspected EF)

An example of the WM fiber visualization at each distance away from the hypometabolic
PET ROI (suspected EF) for one MRE patient (patient #9) is shown in Figure 3.3. In this
patient, visual assessment revealed noticeable differences between ipsilateral (left) and
contralateral (right) fiber bundles in WM 3 mm away from the EF. No notable
differences between ipsilateral and contralateral WM fibers were observed in WM 15 mm
away from the EF.

Figure 3.3: PET-guided diffusion tractography in one MRE patient (patient #9) with a
clinical hypothesis of left temporal lobe focal epilepsy. Ipsilateral (left) and contralateral
(right) WM fibers (coloured lines) are shown for the three WM distances (3, 9, and 15
mm) away from the EF (yellow) identified by AI mapping of FDG-PET. Fewer WM
fibers are observed on the ipsilateral side. Differences in WM fibers between ipsilateral
and contralateral sides appear more prominent at closer distances (3 mm) to the EF.
Abbreviations: L, left; R, right.

When comparing fiber values across the three distances (3, 9, and 15 mm) into
surrounding WM, normalized fiber count, mean FA, and mean fiber length were the
lowest at a distance of 3 mm (Figure 3.4). At 3 mm, normalized mean FA, fiber count,
and mean fiber length were decreased in 14/14 (100%), 13/14 (93%), and 12/14 (86%)
patients, respectively. Normalized mean CS was decreased in 7/14 (50%) patients at this
same distance. Analysis using the Wilcoxon signed-rank test revealed that mean FA was
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significantly decreased at 3 mm compared to 9 mm (p = 0.0031) and 15 mm (p = 0.0004).
Fiber count was the lowest at 3 mm and 9 mm, compared to 15 mm (p < 0.01). Mean
fiber length was significantly reduced across all three distances (p < 0.05). The same
trend was also observed when DTI scalar measurements were made in the WM seed
regions used for tracking around the hypometabolic PET ROI, where mean FA was
decreased at distance 3 mm compared to 9 mm and 15 mm (see Table S3).

Figure 3.4: Quantification of WM fibers around the hypometabolic PET ROI (suspected
EF) in 14 MRE patients. Ipsilateral fiber measurements were normalized to contralateral
fiber measurements as a preliminary measure of WM tract asymmetry. Normalized
values are plotted for the three distances away from the PET ROI. Wilcoxon signed-rank
test was used to compare normalized fiber measurements across the three distances into
surrounding WM (p < 0.05 was considered significant). Fiber count, mean fiber length,
and mean FA are decreased at closer distances to the PET ROI (3 mm) compared to 15
mm (p < 0.05). Abbreviations: *p ! 0.05, **p ! 0.01, ***p ! 0.001.
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3.3.3!

Clinical Assessment of PET/DTI Findings

Table 3.3 summarizes findings from the neurologist’s clinical assessment of the
PET/DTI approach. Eight patients had already undergone surgery. Based on clinical
hypotheses, the MRE cohort consisted of seven temporal lobe, four extratemporal lobe,
and three frontal lobe epilepsy patients. Upon inspection of PET/DTI, WM fiber
abnormalities in the epileptic lobe were observed in 10/14 (71%) patients and these
findings were concordant with the clinical hypothesis. In all 10 patients, diagnostic
confidence improved after presentation of PET/DTI. Specifically, PET/DTI was
contributive in five temporal lobe, three extratemporal lobe, and two frontal lobe epilepsy
patients. Most importantly, PET/DTI indicated that surgical resection could be beneficial
in 3/6 (50%) patients who had not undergone surgery.
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Table 3.3: Clinical assessment of PET/DTI findings
Patient
AI Mapping
PET/DTI

Confidence after
PET/DTI
1
+
+
++
2
+
+
++
3
+
+
+
4
+
+
++
5
+
+
+
6
+
7
8
+
9
+
+
+
10
11
+
+
+
12
+
+
+
13
+
+
+
14
+
+
+
Note: EF localization concordance between AI mapping and the clinical hypothesis is
reported in the second column.
Abbreviations: +, concordant with clinical hypothesis or improved confidence after
PET/DTI; ++, PET/DTI improved confidence and indicated that the patient may benefit
from an anterior temporal lobectomy; -, discordant with clinical hypothesis or unchanged
confidence after PET/DTI.

3.4! Discussion and Conclusions
To our knowledge, this is the first study to simultaneously combine FDG-PET and
diffusion MRI to investigate WM integrity in the brains of MRE patients. We showed
that AI mapping of FDG-PET can successfully detect hypometabolic brain regions
(suspected EF) that are concordant with conventional epilepsy surgical evaluation
techniques (1.5T MRI, EEG, visual PET assessment). We used AI mapping and diffusion
tractography to develop a non-invasive approach that combines PET and MRI
information into one integrated tool (PET/DTI). We demonstrated that our PET/DTI
approach is feasible and can detect epileptic zones in the brains of MRI-negative epilepsy
patients. We localized seizure-onset sites using AI mapping of FDG-PET and tracked
WM fibers from these sites to the rest of the brain using diffusion tractography. This was
achieved by implementing a robust image analysis process standardized for use in each
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patient and adapting readily available imaging analysis tools for ROI mask generation
and subsequent fiber tracking.
The potential clinical impact of PET/DTI in epilepsy surgical evaluation was also
demonstrated in this study. Specifically, we showed that investigation of WM
abnormalities adjacent to seizure-onset zones in the brain can improve diagnostic
confidence in MRE. Furthermore, we found PET/DTI can even indicate that surgical
resection may be beneficial in some MRE patients who have not undergone surgery. Of
course, surgical candidacy of these patients would first need to be reassessed through
future interdisciplinary meetings before concrete decisions to proceed with the resection
can be made. Nevertheless, our findings suggest that PET/DTI can potentially impact
clinical decision-making in epilepsy surgery and is a promising tool for advancing
epilepsy treatment and management.
Numerous standalone PET and diffusion MRI studies have reported functional and
structural alterations in MRE (Henry and Pennell 1998; Knowlton 2006; Focke et al.
2008; Lin et al. 2008; Thivard et al. 2011; James et al. 2015; Labate et al. 2015; Burneo
et al. 2015; Sivakanthan et al. 2016; Jiang et al. 2017; Güvenç et al. 2018; Cahill et al.
2019), however, very few studies have assessed relationships between FDG-PET and
diffusion MRI findings in epilepsy. Similar to our study, one previous report also found
microstructural alterations (decreased FA and increased apparent diffusion coefficient) in
WM adjacent to the epileptic zone identified by FDG-PET hypometabolism (Lippé et al.
2012), while another study revealed that metabolic and structural alterations seen using
FDG-PET and DTI involve similar brain regions in mesial temporal lobe epilepsy
(Aparicio et al. 2016). In contrast to (Lippé et al. 2012) and (Aparicio et al. 2016) who
acquired PET and DTI separately, we used a hybrid PET/MRI scanner to simultaneously
acquire PET and MRI in our study. While this may appear as a trivial difference, this has
profound implications. Patients typically undergo PET and MRI scans on different days,
up to a few months apart. In our cohort, the initial 1.5T MRI evaluation was on average
eight months prior to the clinically indicated PET/CT. Acquiring PET and diffusion MRI
scans separately can create spatial and temporal registration problems, making it difficult
to accurately identify the seizure-onset zone and map its effects on brain structure and
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function undergoing disease-related changes (Wang et al. 2018; Shang et al. 2018).
Misalignment errors are usually due to the subject’s head position being different in
image space between scans which are significantly minimized by hybrid PET/MRI. Coregistration of PET with MRI through multimodal imaging therefore may allow for
improved diagnostic accuracy and more precise EF detection than standalone PET or
MRI, especially in MRI-negative epilepsy (Boscolo Galazzo et al. 2016; Shang et al.
2018).
The majority of the patients with temporal lobe epilepsy in our cohort had apparent
PET/DTI WM abnormalities. This result is consistent with past studies that have
illustrated the utility of diffusion tractography in revealing microstructural breakdown of
WM pathways implicated in drug-resistant temporal lobe epilepsy (Ahmadi et al. 2009;
Sivakanthan et al. 2016), as well as other studies reporting FDG-PET to have higher
sensitivity for detecting the EF in temporal lobe epilepsy patients (70-90%) who had
good surgical outcomes compared to those with other types of epilepsy, especially
extratemporal lobe epilepsy (30-60%) (Sarikaya 2015; Burneo et al. 2015; Aparicio et al.
2016). The surgical success rates in extratemporal lobe epilepsy are much lower than
temporal lobe epilepsy (30-40% vs. 60-70%) with likelihood of achieving long-term
seizure freedom further decreasing in the MRI-negative cases (Téllez-Zenteno et al.
2005; de Tisi et al. 2011), suggesting the possible involvement of intricate neural
networks extending beyond the EF in extratemporal lobe epilepsy that may be
responsible for surgical failure. Interestingly, PET/DTI identified WM abnormalities
around the EF in 3/4 patients with extratemporal lobe epilepsy in our MRE cohort
(patients #1, #4, and #11 in Table 3.3) with improved diagnostic confidence observed in
all three patients. While this is a very small number of patients, we argue this might
provide some preliminary evidence that PET/DTI may potentially shed new insight into
neural networks altered in extratemporal lobe epilepsy and is thus a promising tool for
improving surgical outcomes, even in patients where the EF and its interactions with
surrounding brain tissue extend beyond the temporal lobe.
In our study, PET/DTI was unremarkable in four patients (see patients #6, #7, #8, and
#10 in Table 3.3). Specifically, in patients #6, #7, and #8, all clinical findings lacked
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concordance, with only patient #6 becoming seizure-free after surgery (see Table 3.2). In
patient #10, AI mapping was not concordant with visual PET assessment from the three
clinical readers and the patient showed no improvement after surgery (Engel class IV).
These findings suggest that the four PET/DTI-negative patients in our study may have
had a seizure focus with underlying physiological abnormalities that were too subtle to
confidently detect using neuroimaging. Further research needs to be conducted on why
functional and structural properties measured using PET and MRI are impaired in some
epilepsy patients while in others, they appear intact.
It is well established that FDG-PET is the most sensitive functional imaging tool for
indirectly identifying epileptic regions based on glucose hypometabolism (Knowlton
2006; Burneo et al. 2015; Aparicio et al. 2016). However, glucose hypometabolic regions
identified by PET could extend beyond the true EF especially in extratemporal lobe
epilepsy and may reflect pathophysiology of seizure propagation from the epileptic zone
to surrounding neural networks (Sarikaya 2015; Aparicio et al. 2016). Recent studies
have found that using semi-quantitative approaches, such as AI mapping that extend
beyond visual reads, can not only detect hypometabolic regions in high agreement with
other clinical and electrophysiological findings, but can also increase a reader’s
confidence in their visual assessment of PET (Didelot et al. 2010; Boscolo Galazzo et al.
2016; Shang et al. 2018). Here, we demonstrated – albeit retrospectively – the utility of
AI mapping in epilepsy surgical evaluation, where AI mapping was able to successfully
localize and lateralize the epileptogenic focus in most MRE patients. While it is possible
that some of the metabolic asymmetries observed could simply reflect normal
physiological asymmetries in the brain, especially in patients with multi-focal
hypometabolism, we used a standard AI mapping thresholding approach to isolate
significant hypometabolic brain regions that has been validated by past studies (Boscolo
Galazzo et al. 2016; Shang et al. 2018), which gives us confidence that the metabolic
asymmetries detected in our study are more likely associated with epileptic regions rather
than normal healthy brain tissue. AI mapping is thus a promising tool for guiding
assessment of surgical candidacy in epilepsy, especially in MRI-negative cases.
Furthermore, similar to our findings, past studies have reported FDG-PET
hypometabolism in contralateral brain regions in some epilepsy patients (Aparicio et al.
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2016; Cahill et al. 2019), presumably due to spread of epileptic activity across
hemispheres. Despite these challenges with FDG-PET specificity, we were still able to
show that FDG-PET can aid detection of the epileptogenic zone and assessment of
surgical candidacy in epilepsy, especially when combined with DTI. Perhaps the use of
novel PET tracers targeted to pathogenesis of epilepsy such as imaging reduced synaptic
density using PET-ligands targeting the synaptic vesicle protein 2A (Finnema et al. 2016)
as well as receptor imaging using PET tracers targeting serotonin and gammaaminobutyric acid (Sarikaya 2015; Galovic and Koepp 2016), could increase the
specificity of PET in detecting the true EF.
In this study, we used diffusion tractography to assess structural integrity around MRInegative epileptic zones identified by FDG-PET. Although there is no current gold
standard for validation of WM fibers generated using diffusion tractography techniques,
there are a number of phantom models adapted to simulate WM pathways in healthy
human brains and provide some evaluation of tractography approaches. We empirically
evaluated our diffusion MRI preprocessing and tractography approach to a computersimulated WM phantom (Neher et al. 2014). However, this and other phantom models do
not take into account any GM or WM pathologies present in epilepsy patients (Neher et
al. 2014; Maier-Hein et al. 2017). As such, we opted not to compare WM fibers between
epilepsy patients and a healthy control group, and instead assessed structural integrity by
comparing WM fibers between hemispheres within individual patients. This individual
assessment is more likely to be of clinical utility in epilepsy surgical centers where
epilepsy patients are typically evaluated on a case-by-case basis. Nevertheless, we were
able to show that WM fibers appear to be affected at multiple distances away from the
epileptic tissue. Interestingly, these abnormalities were most apparent in WM directly
surrounding the epileptic zone. While no other studies to date have assessed WM fiber
integrity at different distances from MRI-negative EF sites using WM fiber
quantification, some studies have shown that diffusion tractography can reveal
widespread microstructural changes in drug-resistant epilepsy that could be responsible
for surgical failure (Sivakanthan et al. 2016; Jiang et al. 2017). Our results suggest that
WM directly adjacent to the epileptic zone is most prone to structural alterations. More
specifically, we found that out of the three WM distances investigated, WM anomalies
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were most prominent at an average distance of approximately 3 mm away from the
epileptic zone. This finding suggests that investigation of WM at this distance from
epileptic tissue may better inform clinicians about whether surgery is an option, and if so,
how to properly resect the EF without damaging surrounding healthy brain tissue. This is
especially important to assess in WM affecting memory, language, and visual pathways
in the brain, which are of prime importance in perioperative planning (Lin et al. 2008;
James et al. 2015; Sivakanthan et al. 2016; Li et al. 2019).
Because our AI mapping procedure detected hypometabolism (suspected EF) in cortical
brain areas, we were left with the task of developing a method to track surrounding WM
regions closest to the EF. We sampled WM regions at three incremental distances away
from the epileptic zone using a VOI placed manually in the part of the EF directly
adjacent to surrounding WM. This manual implementation poses a few issues. First,
because we manually defined VOIs in GM regions contralateral to the EF, there is the
possibility of spatial error between ipsilateral and contralateral VOIs. Second, focal
cortical dysplasias and other GM/WM pathologies may result in different amounts of
WM being sampled between ipsilateral and contralateral regions. However, it is
conceivable that any differences in WM size between ipsilateral and contralateral regions
are presumably small and are likely offset by the noticeable WM fiber abnormalities
observed around the EF in the majority of our MRE patient cohort.
The clinical potential of the proposed PET/DTI approach could be impacted by the
relatively small size of our heterogeneous MRE patient cohort, making it difficult to draw
any conclusions regarding what epilepsy patient groups are most likely to benefit from
PET/DTI. However, the purpose of this hybrid PET/MRI study was to demonstrate the
feasibility of PET/DTI and provide some preliminary assessment on whether PET/DTI
could potentially impact clinical decision-making in epilepsy surgery, particularly in
MRI-negative epilepsy where FDG-PET could instead be used to non-invasively locate
the EF. Of note, hybrid PET/MRI relies on MR-based attenuation correction (MRAC) for
PET reconstruction instead of CT-based AC used in PET/CT, which is the current clinical
standard for FDG-PET imaging in epilepsy. While some studies show that traditional
MRAC approaches can produce small bias in quantitative PET due to inadequate
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modelling of bone (Larsson et al. 2013; Andersen et al. 2014), recent reports have
revealed that these MRAC biases do not significantly impact clinical diagnosis of FDGPET readings in epilepsy (Paldino et al. 2017; Oldan et al. 2018). Nevertheless,
alternative MRAC methods have been proposed to reduce potential bias in reconstructed
PET (Ladefoged et al., 2017). In our study, we used an improved robust MRAC method
(Ladefoged et al. 2015) that adequately models bone tissue information to produce
PET/MR images that provide comparable diagnostic information to PET/CT.
Because clinical assessment of our PET/DTI approach was retrospectively completed by
one neurologist, potential interobserver variability could not be determined from this
study. A potential future direction of this research is to pilot a prospective study to assess
the clinical utility of combined PET/DTI through interdisciplinary meetings that would
evaluate MRE patients both with and without including our PET/DTI approach to
determine whether this approach will have any impact on the final surgical decision in
these patients.
In general, this retrospective study demonstrated the feasibility of combining PET and
DTI to investigate WM integrity in the brains of MRE patients to further enhance clinical
decision-making in epilepsy surgery. An extension of this study could combine functional
MRI (fMRI) with DTI and PET to map out the structure and function of brain networks
in the presence of seizure-related brain abnormalities. fMRI is another non-invasive
imaging modality that may have promising applications in neurosurgical planning. While
DTI investigates structural connections, fMRI measures functional correlates between
brain regions based on differences in blood flow and can be used to effectively map
neural connections in the brain (Bettus et al. 2009, 2010; Fox and Greicius 2010; Moeller
et al. 2011; Pittau et al. 2012). By combining structural and functional connectivity
analysis, we would be able to even better characterize seizure sites in MRE surgical
candidates. We plan to incorporate PET, DTI, and fMRI modalities into an integrated
software platform that would allow clinicians to non-invasively probe healthy brain tissue
and areas around the epileptic zone to further improve neurosurgical planning, especially
in challenging epilepsy cases where MRI and IC-EEG findings lack concordance. The
integration and proper use of these non-invasive imaging modalities will help advance the
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field of epilepsy treatment and management and may lead to completely non-invasive
epilepsy surgical planning (Knowlton 2006; Sivakanthan et al. 2016).
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Table S1. EEG and MRI findings from clinical reports and visual assessment

3.5! Supplementary Tables
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Contralateral
ROI
3.16
8.00
6.82
2.16
3.94
7.48
2.70
8.14
4.04
5.43
8.09
6.73
7.98
5.78
5.75 ± 2.18

Max SUV
Hypometabolic
ROI
3.11
5.89
6.41
2.06
4.17
6.68
4.05
8.29
3.89
5.10
7.67
7.25
8.58
5.00
5.58 ± 2.00
Contralateral
ROI
4.10
9.45
7.86
2.69
5.46
8.75
4.78
10.85
5.08
6.60
11.16
9.69
10.68
6.46
7.40 ± 2.76

Note: For mean SUV and mean ZAI, group values are reported as mean ± standard deviation.

Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Group

Mean SUV
Hypometabolic
ROI
2.24
4.90
4.81
1.63
3.03
5.35
2.01
4.66
2.83
3.87
5.87
4.95
6.16
4.34
4.04 ± 1.47

Mean ZAI
Hypometabolic
ROI
-2.30
-2.10
-2.70
-2.20
-2.07
-2.34
-3.21
-3.42
-2.66
-2.73
-2.12
-2.53
-2.33
-2.71
-2.53 ± 0.41

Contralateral
ROI
2.02
1.93
2.40
1.83
1.69
1.96
2.85
3.09
2.31
2.37
1.87
2.19
1.95
2.35
2.20 ± 0.40

Table S2. SUV analysis in hypometabolic PET ROIs and contralateral ROIs from AI mapping in 14 MRE patients

parietal lobe; R, right; SH, subcortical heterotopia; temp, temporal lobe.

Abbreviations: *, equivocal finding; FCD, focal cortical dysplasia; front, frontal lobe; L, left; MTS, mesial temporal sclerosis; par,
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Contralateral
ROI
0.18
0.17
0.13
0.14
0.05
0.15
0.02
0.17
0.19
0.18
0.14
0.10
0.13
0.16
0.13 ± 0.05

9 mm into WM
Hypometabolic
ROI
0.15
0.11
0.26
0.12
0.08
0.15
0.03
0.11
0.22
0.21
0.16
0.12
0.19
0.24
0.15 ± 0.06

Note: Group values are reported as mean ± standard deviation.

Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Group

3 mm into WM
Hypometabolic
ROI
0.08
0.07
0.14
0.08
0.06
0.10
0.01
0.08
0.12
0.12
0.07
0.05
0.13
0.13
0.09 ± 0.04

mapping of FDG-PET
Contralateral
ROI
0.12
0.19
0.22
0.14
0.06
0.26
0.04
0.16
0.26
0.21
0.22
0.09
0.18
0.29
0.17 ± 0.08

15 mm into WM
Hypometabolic
ROI
0.16
0.12
0.28
0.13
0.08
0.19
0.06
0.13
0.24
0.22
0.15
0.10
0.18
0.26
0.16 ± 0.07

Contralateral
ROI
0.13
0.16
0.24
0.16
0.07
0.27
0.05
0.20
0.25
0.20
0.19
0.09
0.18
0.31
0.18 ± 0.08

Table S3. Regional FA analysis in WM surrounding hypometabolic PET ROIs and contralateral ROIs detected by AI
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Chapter 4!!

4!

Conclusions and Future Directions

4.1! Conclusions
The overall goal of this thesis was to develop a hybrid PET/MRI approach to noninvasively localize EF and assess structural integrity around EF for improving DRE
surgical evaluation. Our first aim was to assess the diagnostic competence of hybrid
PET/MRI against PET/CT, the current clinical standard for FDG-PET imaging in
epilepsy, to evaluate whether quantitative PET biases from MRAC have any significant
impact on clinical diagnosis of DRE. Our second aim was to develop a PET/DTI
approach for assessing WM integrity around EF in MRI-negative DRE patients and to
evaluate the potential clinical utility of PET/DTI in guiding clinical decision making in
epilepsy surgery. These two research objectives were addressed in Chapters 2 and 3.
Findings from both chapters will be summarized in this section.
In Chapter 2, we evaluated the diagnostic equivalency and clinical value of hybrid
PET/MRI against PET/CT in DRE. Diagnostic equivalency was assessed by comparing
regional MRAC biases in FDG-PET images between PET/MRI and PET/CT. Clinical
value of hybrid PET/MRI in DRE localization was assessed by qualitatively and
quantitively comparing FDG-PET findings from PET/MRI against clinical reports and
gold-standard post-surgical outcomes. We found that visual FDG-PET readings between
PET/MRI and PET/CT were similar and yielded comparable diagnostic outcome.
Likewise, we found that quantitative PET bias was low between PET/MRI and PET/CT,
suggesting that PET/MRI can provide similar metabolic information as PET/CT. In
general, PET/MRI with optimal MRAC can yield similar diagnostic performance as
PET/CT. Indeed, hybrid PET/MRI is a reliable method for detecting EF in DRE and is a
promising tool for improving epilepsy treatment and management.
In Chapter 3, we developed a PET/DTI approach combining FDG-PET and diffusion
MRI to investigate WM integrity in the brains of MRI-negative DRE patients. We used
AI mapping of FDG-PET to detect the EF and used diffusion tractography to assess WM
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fiber integrity around the EF. We found that AI mapping of FDG-PET can successfully
detect seizure-onset zones that are concordant with clinical reports, EEG findings, and
visual FDG-PET assessment. PET/DTI revealed structural alterations around the EF in
the majority of our MRI-negative epilepsy cohort. In general, PET/DTI combines PET
and MRI information into one integrated platform and is a promising tool for improving
surgical outcomes, especially in MRI-negative epilepsy where we can use FDG-PET to
detect the EF. Specifically, PET/DTI can improve diagnostic confidence in DRE and
could potentially impact clinical decision-making in epilepsy surgery. Indeed,
multimodal brain imaging combining PET and MRI information can help advance
epilepsy treatment and management, which could lead to improved surgical outcomes
and better patient quality of life.

4.2! Future Directions
The hybrid PET/MRI research discussed in this thesis showed the feasibility of PET/DTI
in localizing EF and assessing WM integrity around EF in DRE. In the future, we plan to
incorporate functional MRI (fMRI) into our PET/DTI approach to map out functional
connections in the brain. Combining PET with DTI and fMRI could provide new insight
into brain connectivity affected in epilepsy and may improve characterization of EF and
surrounding brain regions to further enhance neurosurgical planning.
In this thesis, we found that AI mapping of FDG-PET can detect contralateral
hypometabolism in some epilepsy patients, a finding that is consistent with past studies.1,2
While a previous report has suggested that contralateral FDG-PET hypometabolism may
be a compensatory mechanism against functional deficits in the ipsilateral lobe3, another
study has shown that bilateral temporal lobe hypometabolism is associated with increased
epilepsy duration and poorer surgical outcome.4 It is evident that multi-focal
hypometabolism is an issue, especially in patients who have multiple, non-continuous
hypometabolic regions extending well beyond the seizure-onset zone and can lead to
false lateralization of AI mapping. Hence, a course of future direction could further
improve specificity of AI mapping in EF localization through statistical comparison of AI
values between patients and an age-matched healthy control FDG-PET/MRI database.
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There are a few interesting future avenues of epilepsy DTI research that should be noted.
First, DTI scalar parameters can vary diurnally. Specifically, FA has been shown to
decrease as the day progresses.5 It would be interesting to investigate whether changes in
DTI scalar values due to different patient scanning times can significantly affect FA and
diffusion tractography results in epilepsy. Second, structural integrity of individual WM
fiber pathways known to be affected in epilepsy, such as the uncinate fasciculus and
fornix, and their potential relationships to FDG-PET metabolic alterations, especially
around the EF, could be assessed to even better enhance characterization of EF and its
relationships with surrounding neural networks. Finally, we plan to further improve our
diffusion MRI image analysis pipeline by implementing automated quality control steps6
to enhance detection of bad quality DWI data.
This thesis demonstrated the potential clinical utility of PET/DTI in epilepsy surgical
evaluation. In the future, we plan to pilot a prospective study to assess the potential added
value of PET/DTI in epilepsy surgical decision-making. Efforts are currently underway to
extend this work to the pediatric population to gain new insight into functional and
structural alterations that take place in different epilepsy patient groups. The goal is to
provide clinicians with an interactive platform to non-invasively probe brain areas
affected by seizures in vivo to determine whether a patient is suitable for surgery. This
will further minimize potential risks associated with surgical resection, and in turn lead to
better surgical outcomes and overall quality of life.
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Appendix A: Empirical evaluation of diffusion tractography
pipeline using whole-brain tractograms from a white matter
phantom
Before diffusion tractography, DWI images are preprocessed to remove noise, subject
motion, and other image artifacts. Many different approaches exist for preprocessing
DWI data which can impact the accuracy of WM fiber reconstruction. Here, we
empirically evaluated our diffusion tractography pipeline (see Figure A.1 below) using
the

ground-truth

phantom

from

the

ISMRM

2015

Tractography

Challenge

(http://www.tractometer.org/). Whole-brain WM fiber tracts (tractograms) from both the
artifact-free phantom and the challenge phantom dataset were scored and compared to an
online database of other tractograms. This work was accepted and presented at ImNO as
a conference abstract:
Poirier SE, Thiessen JD, Anazodo UC (2019). Empirical evaluation of a DTI
tractography pipeline using whole-brain tractograms from a white matter phantom. 17th
Annual Imaging Network Ontario (ImNO) Symposium, London, Canada. Abstract.
Accepted – Oral Presentation.
Methods: Phantom DWI data preprocessing and pipeline scoring
The phantom DWI data, which contained noise, motion, and image artifacts, were
generated using Fiberfox (Neher et al., MRM, 2014) from 25 computer-simulated WM
bundles with the following parameters; 2 mm isotropic resolution, 32 contiguous slices,
b-values = 0, 1000 s/mm2 and 32 diffusion-encoding gradient directions. The phantom
DWI data were preprocessed using our diffusion MR image analysis pipeline to generate
whole-brain tractograms. Tractograms were scored using the scoring system from the
ISMRM 2015 Tractography Challenge, which compared streamlines to the ground-truth
bundles and generated the following parameters; valid bundles (VB) – scored out of 25,
invalid bundles (IB) – number of bundles that did not exist in ground-truth phantom,
valid connections (VC), invalid connections (IC), and no connections (NC).
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Figure A.1: Diffusion tractography pipeline scoring. Phantom DWI data were
preprocessed to generate whole-brain tractograms. The whole-brain tractograms were
scored using the scoring system from the ISMRM 2015 Tractography Challenge.
Results: Pipeline scores
Scores from the artifact-free phantom: VB = 24/25, IB = 76, VC = 85.78%, IC = 14.21%,
NC = 0.00%. Scores from the challenge phantom data: VB = 23/25, IB = 70, VC =
70.37%, IC = 29.63%, NC = 0.00%. Whole-brain tractograms for the artifact-free and
challenge phantom data are shown in Figure A.2 below.
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Figure A.2: WM tractograms. Whole-brain tractograms from (A) artifact-free phantom
and (B) challenge phantom dataset.
Summary
We empirically evaluated our diffusion tractography pipeline using a ground-truth
diffusion phantom dataset. Comparing our whole-brain tractogram scores to the online
submissions database (http://www.tractometer.org/ismrm_2015_challenge/results), we
found that our pipeline performed very well across all five scoring parameters (mean
score percentile = 76 ± 24%) and this gives us confidence that our pipeline is indeed
accurately reconstructing WM fiber pathways in the brain.
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